Michael W. Russell  PhD

Department of Oral Biology

Professor of Microbiology & Immunology and Oral Biology

Specialty/Research Focus

Immunology; Infectious Disease; Microbial Pathogenesis; Microbiology

Faculty Research Profile

 
top-left cornertop-right corner
Professional Summary:

Mucosal immunologist, with par

Education and Training:
  • PhD, Microbiology, University of Reading (1973)
  • MA, University of Cambridge (1970)
  • BA, Natural Sciences: Biochemistry, University of Cambridge (1966)
Employment:
  • Adjunct Professor, Microbiology and Immunology, University of Alabama at Birmingham (2000-present)
  • Professor, Microbiology and Immunology, University at Buffalo (2000-present)
  • Professor (tenured 2002), Microbiology & Immunology, State University of New York at Buffalo (2000-present)
  • Professor (tenured 2002), Oral Biology, State University of New York at Buffalo (2000-present)
  • Adjunct Professor, Department of Microbiology, University of Alabama (2000-present)
  • Director, Witebsky Center for Microbial Pathogenesis and Immunology, Microbiology and Immunology, State University of New York at Buffalo (2004-2006)
  • Associate Director, Witebsky Center for Microbial Pathogenesis and Immunology, Microbiology and Immunology, State University of New York at Buffalo (2002-2004)
  • Senior Scientist, University of Alabama (1995-2000)
  • Deputy Director, University of Alabama (1994-1997)
  • Senior Scientist, University of Alabama (1993-2000)
  • Senior Scientist, University of Alabama (1993-2000)
  • Senior Scientist, University of Alabama (1993-2000)
  • Research Professor, Microbiology and Immunology, University of Alabama at Birmingham (1992-2000)
  • Research Professor, Department of Microbiology, University of Alabama (1992-2000)
  • Research Professor, Department of Oral Biology, University of Alabama (1992-2000)
  • Senior Scientist, Research Center for Oral Biology, Oral Biology, State University of New York at Buffalo (1992-2000)
  • Associate Investigator, University of Alabama (1991-2000)
  • Associate Scientist, University of Alabama (1989-1992)
  • Investigator, University of Alabama (1987-1992)
  • Visiting Associate Professor (Lektovikar), Oral Biology, Royal Dental College (1987-1988)
  • Visiting Associate Professor, Aarhus University (1987-1988)
  • Research Associate Professor, Microbiology and Immunology, University of Alabama at Birmingham (1986-1992)
  • Research Associate Professor, Department of Microbiology, University of Alabama (1986-1992)
  • Graduate Faculty, Cellular and Molecular Biology Program, University of Alabama (1984)
  • Research Assistant Professor, Department of Microbiology, University of Alabama (1982-1986)
  • Research Assistant Professor, Microbiology and Immunology, University of Alabama at Birmingham (1982-1986)
  • Visiting Investigator, Department of Microbiology, University of Alabama (1979-1981)
  • Professional Staff, Microbiology and Immunology, University of Alabama at Birmingham (1979-1981)
  • Temporary Lecturer, Guy‘s Hospital Medical and Dental Schools (1978)
  • Honorary Lecturer, Guy‘s Hospital Medical and Dental Schools (1977)
  • Professional Staff, Accounting and Law, Guy's Hospital Medical and Dental schools (1972-1979)
  • Post-doctoral Research Fellow, Oral Immunology and Microbiology, Guy‘s Hospital Medical and Dental Schools (1972-1979)
  • Research Student, Bacteriology, National Institute for Research in Dairying, and Microbiology, University of Reading (1968-1972)
  • Voluntary Service Overseas, Nairobi, Kenya, Nairobi, Kenya (1966-1967)
See All (34 Total) >
Awards and Honors:
  • NIH Merit Award, NIDCR (2008)
  • American Society for Microbiology Branch Lectureships (2008)
  • NIH Merit Award, NIDCR (2007)
  • Distinguished Scientist Award for Research in Oral Biology, IADR (2007)
  • NIH Merit Award, NIDCR (2006)
  • Inventor of the Year (First Place - Life Sciences; 2005) (2005)
  • NIH Merit Award, NIDCR (2005)
  • NIH Merit Award, NIDCR (2004)
  • NIH Merit Award, NIDCR (2003)
  • NIH Merit Award, NIDCR (2002)
  • NIH Merit Award, NIDCR (2001)
  • NIH Merit Award, NIDCR (2000)
  • Fellow of the American Academy of Microbiology (2000)
  • NIH Merit Award, NIDCR (1999)
  • Open Scholarship, St. John's College, Cambridge, England (1963)

Research Centers:
  • Witebsky Center for Microbial
UB 2020 Strategic Strengths:
  • Molecular Recognition in Biolo
Grants and Sponsored Research:
  • April 2014-March 2019
    Experimental gonorrhea vaccine
    NIH
    Role: Co-Investigator
    $655,000.00
  • February 2013-January 2014
    Therapy and prophylaxis for genital tract infection
    NIH
    Role: Co-Investigator
    $200,000.00
  • December 2010-November 2013
    Imaging antigen and adjuvant uptake for enhancing response to mucosal vaccines
    NIH
    Role: Principal Investigator
    $301,621.00
  • December 2008-January 2012
    Gonococcal inflammatory immune responses
    NIH
    Role: Principal Investigator
    $273,750.00
  • July 2008-June 2012
    The Th17 axis of immunity in infectious and autoimmune defects
    The John R. Oishei Foundation, Buffalo, NY
    Role: Principal Investigator
    $200,000.00
  • August 2006-July 2011
    Type II enterotoxins as mucosal immunomodulators
    National Institutes of Health
    Role: Co-Investigator
    $1,150,000.00
  • June 2000-May 2006
    Mucosal vaccines against gonorrhea
    NIH
    Role: Principal Investigator
    $825,000.00
  • September 1994-June 1999
    Mucosal immunity in gonococcal infection
    NIH
    Role: Principal Investigator
    $609,627.00
  • September 1994-September 1999
    Maternal influences on mucosal immunity in infants
    NIH
    Role: Principal Investigator
    $285,451.00
  • December 1992-April 2000
    Regulation of cellular inflammatory responses by IgA
    NIH
    Role: Principal Investigator
    $685,458.00
  • December 1992-April 2000
    Research Center for Oral Biology (Director: S.M. Michalek) Project #II -Regulation of cellular inflammatory responses by IgA
    NIH
    Role: Co-Investigator
    $685,458.00
  • January 1991-June 2004
    IgA antibodies in periodontal inflammation
    NIH
    Role: Principal Investigator
    $1,092,110.00
  • January 1984-December 2010
    Antigens of Streptococcus mutans in caries immunity
    NIH
    Role: Principal Investigator
    $2,579,750.00
See All (13 Total) >
Patents:
  • Combined therapy and prophylaxis for genital tract infection: Combined therapy and prophylaxis for genital tract infection; (2013)
  • Anti-immunosuppresive therapy and prophylaxis for genital tract infection: Anti-immunosuppresive therapy and prophylaxis for genital tract infection; (2012)
  • Adjuvant Activities of Mutants of LT-IIa and LT-IIb Enterotoxin Lacking Bin; (2008)
  • Chimeric TBP-Toxin Proteins As Mucosal Adjuvants for Vaccination Against Ne: US provisional patent application filed June 24, 2005; PCT application #US2006/023879 filed June 20, 2006; US non-provisional patent application #11/963,110 filed December 21, 2007.; (2007)
  • Adjuvant Activities of B Pentamers of LT-IIa and LT-IIb Enterotoxin: US provisional patent filed February 15, 2005; US non-provisional patent application #11/354,497 filed February 15, 2006.; (2006)
  • Chimeric Antigen-Enterotoxin Mucosal Immunogens: The present invention provides methods of inducing immune responses by recombinant antigen-enterotoxin chimeric mucosal immunogens that contain the A2/B subunits of cholera toxin or heat-labile type II toxins. These chimeric immunogens differentially enhance antibody secretion, cytokine production, as well as B7-dependent co-stimulation of T cells and CD40L expression of CD4.sup. + T cells. International patent pending.; (2005)
  • Adjuvant Activities of a Mutant LT-IIb Enterotoxin: US provisional patent application filed September 25, 2003; US non-provisional and PCT patent applications filed September 27, 2004.; (2003)
  • Mucosal Immunogens for Novel Vaccines: The present invention provides chimeric proteins such as Salivary Binding Protein (SBR) coupled to the B subunit of cholera toxin. Such a chimeric protein, when expressed in attenuated Salmonella typhymurium produces significant increases in serum IgG and salivary IgA antibody levels after oral immunization. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin A2/B chimeric protein expressed in E. coli. Intragastric immunization of SBR coupled to CTB in this chimeric protein from leads to increased antigen responsive T cells. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin.sup. DELTA.A1 chimeric protein expressed in Salmonella typhimurium. Oral immunization using this recombinant plasmid results in increased serum IgG responses to antigen. Oral immunization using this recombinant plasmid also resulted in increased salivary IgA antibody responses to antigen.; (2000)
  • Improvements In Or Relating To Vaccines - Japan; (1981)
  • Improvements In Or Relating To Vaccines - UK; (1980)
  • Improvements In Or Relating to Vaccines - U.K.; (1979)
  • Improvements in or relating to vaccines; (1979)

Journal Articles:
  • Liu Y Liu W Russell MW . Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells Mucosal Immunology. 2014; 7(1).
  • Zhao W, Minderman H, Russell MW. Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry. Clinical and Vaccine Immunology. 2014; 21(1).
  • Liu Y Egilmez NK Russell MW. Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated IL-12 Journal of Infectious Diseases. 2013; 208.
  • Feinen B Russell MW. Contrasting roles of IL-22 and IL-17 in murine genital tract infection by Neisseria gonorrhoeae Frontiers in Immunology. 2012; 3.
  • Liu Y Islam E Jarvis GA Gray-Owen S Russell MW . Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms Mucosal Immunology. 2012; 5(3).
  • Liu, Y, Feinen, B, Russell MW. New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host Frontiers in Microbiology. 2011; 2.
  • Liu, Y, Russell MW. Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by treatment with anti-TGF-β antibody generates immunological memory and protective immunity mBio. 2011; 2.
  • Woof JM, Russell MW. Structure and Function Relationships in IgA Mucosal Immunology. 2011; 4(6).
  • Zhao, W, Zhao, Z, Russell MW,. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins Molecular Oral Microbiology. 2011; 26.
  • Feinen B, Jerse AE, Gaffen SL, Russell MW. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal Immunology. 2010; 3.
  • Russell MW, Mestecky J. Tolerance and protection against infection in the genital tract Immunological Investigations. 2010; 39.
  • Russell MW, Ogra PL. Mucosal decisions: tolerance and responsiveness at mucosal surfaces Immunological Investigations. 2010; 39.
  • Liang S, Hosur KB, Nawar HF, Russell MW, Connell TD, Hajishengallis G. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. Vaccine. 2009; 27(32).
  • Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces Immunological Letters. 2009; 124.
  • Ostberg KL, Russell MW, Murphy TF. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae Mucosal Immunol. 2009; 2.
  • Brandtzaeg, P, Kiyono, H, Pabst, R, Russell M. Terminology: Nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol.. 2008; 1.
  • Pabst R, Russell MW, Brandtzaeg P. Tissue distribution of lymphocytes and plasma cells and the role of the gut (letter). Trends Immunol. 2008; 29.
  • Arce S, Nawar HF, Muehlinghaus G, Russell MW, Connell TD. In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis. Infect Immun. 2007; 75(3).
  • Guerrero, GG, Russell M, Moreno-Fierros, L. Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1A toxins in mice: Effect of the hydrophobic motif from diphtheria toxin. Mol. Immunol.. 2007.
  • Liang S, Wang M, Triantafilou K, Triantafilou M, Nawar HF, Russell MW, Connell TD, Hajishengallis G. The A subunit of type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2. J Immunol. 2007; 178(8).
  • Mestecky J, Russell MW, Elson CO. Perspectives on oral vaccines Journal of Immunology. 2007; 179.
  • Nawar HF, Arce S, Russell MW, Connell TD. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Infect Immun. 2007; 75(2).
  • Price GA, Masri HP, Hollander AM, Russell MW, Cornelissen CN. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice Vaccine. 2007; 25.
  • Michalek, S, Russell M, Kaetzel, C, Johansen, F-E. pIgR/IgA sessions I and II: Summary. Mucosal Immunology Update. 2006; 14(2).
  • Arce S, Nawar HF, Russell MW, Connell TD. Differential binding of Escherichia coli enterotoxins LT-IIa, LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells. Infect Immun. 2005; 73.
  • Gockel CM, Russell MW. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein. Immunology. 2005; 116(4).
  • Hajishengallis G, Arce S, Gockel CM, Connell TD, Russell MW. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. J Dent Res. 2005; 84(12).
  • Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol. 2005; 53(5).
  • Nawar H, Arce S, Russell MW, Connell TD. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. Infect Immun. 2005; 73.
  • Price GA, Russell MW, Cornelissen CN. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Infect Immun. 2005; 73(7).
  • Hajishengallis G, Nawar H, Tapping RI, Russell MW, Connell TD. The type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells. Infect Immun. 2004; 72.
  • Russell MW, Childers NK, Michalek SM, Smith DJ, Taubman MA. A caries vaccine? The state of the science of immunization against dental caries. Caries Res. 2004; 38.
  • Hajishengallis G, Martin M, Sojar H, Sharma A, Schifferle R, DeNardin E, Russell MW, Genco RJ. Dependence of bacterial protein adhesin on toll-like receptors and proinflammatory cytokine induction Clin Diagn Lab Immunol. 2002; 9(2).
  • Hajishengallis G, Sharma A, Russell MW, Genco RJ. Interactions of Oral Pathogens with Toll-Like Receptors: Possible Role in Atherosclerosis. Ann Periodontol. 2002; 27(1).
  • Hajishengallis G, Sharma A, Russell MW, Genco RJ. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis. Ann Periodontol. 2002; 7.
  • Hajishengallis H, Martin M, Sojar H, Sharma A, Schifferle R, DeNardin E, Russell MW, Genco RJ. Dependence of Bacterial Protein Adhesion on Toll-Like Receptors for Proinflammatory Cytokine Induction Clin Diagn Lab Immunol. 2002; 9.
  • Hajishengallis H, Sharma A, Russell MW, Genco R. Interactions of Oral Pathogens With Toll-Like Receptors: Possible Role in Atherosclerosis Ann Periodontol. 2002; 7.
  • Jespersgaard C, Hajishengallis G, Russell MW, Michalek SM. Identification and characterization of a nonimmunoglobulin factor in human saliva that inhibits Streptococcus mutans glucosyltransferase. Infect Immun. 2002; 70(3).
  • Michael Russell. Immunization for protection of the reproductive tract: a review Am. J. Reprod. Immunol.. 2002; 47.
  • Michael Russell, Mestecky, J.. Humoral immune responses to microbial infections in the genital tract Microb. Infect.. 2002; 4.
  • Russell MW. Mucosal immunity. New Bacterial Vaccines (In Press). 2002.
  • Harrod T, Martin M, Michael Russell. Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol Immunol. 2001; 16(3).
  • Jespersgaard C, Zhang P, Hajishengallis G, Russell MW, Michalek SM. Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein. Infect Immun. 2001; 69(11).
  • Martin M, Hajishengallis G, Metzger DJ, Michalek SM, Connell TD, Russell MW. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Infect Immun. 2001; 69(1).
  • Martin M, Metzger DJ, Michalek SM, Terry Connell, 0F70L4CU7W. Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) t cells. Infect Immun. 2001; 69(7).
  • Michael Russell. Potential for vaccines in the prevention of caries lesions Oper. Dent.. 2001; 6.
  • Michael Russell, Martin MH, Wu HY, Hollingshead SK, Moldoveanu Z, Mestecky J. Strategies of immunization against mucosal infections. Vaccine. 2001; 19 Su.
  • Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW, Mestecky J, M. Urethral cytokine and immune responses in Chlamydia trachomatis-infected males. Infect Immun. 2001; 69(11).
  • Russell MW. Potential for vaccines in the prevention of caries lesions. Oper Dent. 2001; Sup..
  • Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Michael Russell, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF, Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol. 2001; 167(5).
  • Zivny JH, Moldoveanu Z, Vu HL, Russell MW, Mestecky J, Elson CO, M. Mechanisms of immune tolerance to food antigens in humans. Clin Immunol. 2001; 101(2).
  • Martin M, Metzger DJ, Michalek SM, Terry Connell, Russell MW. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect Immun. 2000; 68(1).
  • Mestecky J, Michael Russell. Induction of mucosal immune responses in the human genital tract. FEMS Immunol Med Microbiol. 2000; 27(4).
  • Russell MW, Martin MH, Wu HY, Hollingshead SK, Moldoveanu Z, Mestecky J, M. Strategies of immunization against mucosal infections. Vaccine. 2000; 19 Su.
  • Vu HL, Troubetzkoy S, Nguyen HH, Michael Russell, Mestecky J. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis. Nucleic Acids Res. 2000; 28(7).
  • Wu HY, Abdu S, Stinson D, Michael Russell. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun. 2000; 68(10).
  • Childers NK, Tong G, Mitchell S, Kirk K, Michael Russell, Michalek SM. A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. Infect Immun. 1999; 67(2).
  • Hedges SR, Mayo MS, Mestecky J, Hook EW, Michael Russell. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun. 1999; 67(8).
  • Jespersgaard C, Hajishengallis G, Greenway TE, Smith DJ, Michael Russell, Michalek SM. Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I. Infect Immun. 1999; 67(2).
  • Jespersgaard C, Hajishengallis G, Huang Y, Michael Russell, Smith DJ, Michalek SM. Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Infect Immun. 1999; 67(12).
  • Mestecky J, Michael Russell, Elson CO. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut. 1999; 44(1).
  • Michael Russell, Georgios Hajishengallis, Childers, N.K., Michalek, S.M.. Secretory immunity in defense against mutans streptococci (Review) Caries Res.. 1999; 33.
  • Michael Russell, Georgios Hajishengallis, Wu, H.-Y., Hollingshead, S.K., Briles, D.E., Moldoveanu, Z., Michalek, S.M., Mestecky, J.. Recombinant CTB-linked mucosal regions of Streptococcus mutans glucosyltransferase-1. Infect. Immun.. 1999; 67.
  • Michael Russell, Hajishengallis G, Childers NK, Michalek SM. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res. 1999; 33(1).
  • Michael Russell, Hedges SR, Wu HY, Hook EW, Mestecky J. Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review. Am J Reprod Immunol. 1999; 42(1).
  • Michael Russell, Sibley, D.A.. IgA as an anti-inflammatory regulator of immunity Oral Dis.. 1999; 5.
  • Michael Russell, Singer, R., Lamster, I.. IgA and periodontal disease: Summary and conclusions Oral Dis.. 1999; 5.
  • Michael Russell, Wu HY, Hajishengallis G, Hollingshead SK, Michalek SM. Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery. Adv Vet Med. 1999; 41.
  • Russell MW, Hajishengallis G, Childers NK, Michalek SM. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res. 1999; 33.
  • Russell MW, Sibley DA. IgA as an anti-inflammatory regulator of immunity. Oral Dis. 1999; 5.
  • Russell MW, Singer R, Lamster I. IgA and periodontal disease: Summary and conclusions. Oral Dis. 1999; 5.
  • Russell MW, Wu H-Y, Hajishengallis G, Hollingshead SK, Michalek SM. Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery. In: Schultz, RD (ed.) Veterinary Vaccines and Diagnostics. Adv Vet Med. 1999; 41.
  • Hajishengallis G, Michael Russell, Michalek SM. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun. 1998; 66(4).
  • Hedges SR, Mayo MS, Kallman L, Mestecky J, Hook EW, Michael Russell. Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect Immun. 1998; 66(12).
  • Hedges SR, Sibley DA, Mayo MS, Hook EW, Michael Russell. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J Infect Dis. 1998; 178(3).
  • Hedges, S.R., Russell M, Mestecky, J.. Diagnostic significance of antibodies in oral secretions. Chapter 4. Rapid Detection of Infectious Agents.. 1998.
  • Matesky J, Moldoveanu Z, Russell MW, Russell MW. Factors affecting mucosal vaccination. Proc Int Symp Contr Rel Bioact Mater. 1998; 25.
  • Mestecky J, Michael Russell. Passive and active protection against disorders of the gut. Vet Q. 1998; 20 Su.
  • Mestecky JM, Russell MW. Passive and active protection against disorders of the gut. Vet Quart. 1998; 20.
  • Pate, M.S., Hook, E.W., Hedges, S.R., Sibley, D.A., Russell M, Mestecky, J.. Chlamydia infected male urethra cytokine detection and profile. Chlamydial Infections.. 1998.
  • Russell M. Future strategies to control oral infections. Oral Biology at the Turn of the Century: Misconceptions, Truths, Challenges, and Prospects.. 1998.
  • Turner MW, Russell MW, Gleeson M, Brandtzaeg P, Ferguson A, Hanson LA, Lamm ME, Mestecky J, Moro I, Underdown BJ, Vaerman JP. Nomenclature of immunoglobin A and other proteins of the mucosal immune system. Bull Wld Hlth Org. 1998; 76.
  • Wu HY, Michael Russell. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine. 1998; 16(2-3).
  • Harokopakis E, Hajishengallis G, Greenway TE, Russell MW, Michalek SM, M. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect Immun. 1997; 65(4).
  • Mestecky J, Michalek SM, Moldoveanu Z, Russell MW, M. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst Mitt. 1997(98).
  • Mestecky J, Moldoveanu Z, Michalek SM, Morrow C, Compans RW, Schafer DP, Russell MW. Current options for vaccine delivery systems by mucosal routes. J Controlled Release. 1997; 48.
  • Mestecky J, Russell MW, M. Mucosal immunoglobulins and their contribution to defence mechanisms: an overview. Biochem Soc Trans. 1997; 25(2).
  • Mestecky, J., Michalek, S.M., Moldoveanu, Z., Kutteh, W.H., Crowley-Nowick, P.A., Morrow, C., Russell M. Target mucosal immunizations: antigens delivery systems and compartmentalization of the common mucosal immune system. Mucosal Solutions: Advances in Mucosal Immunology.. 1997; 2.
  • Mestecky, J., Moldoveanu, Z., Michalek, S.M., Morrow, C., Compans, R.W., Schafer, D.P., Michael Russell. Current options for vaccine delivery systems by mucosal routes J. Controlled Release. 1997; 48.
  • Michael Russell , Wu, H.-Y.. Nasal-associated lymphoid tissue and mucosal vaccine development. Mucosal Immunology Update. 1997; 5.
  • Michael Russell, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans. 1997; 25(2).
  • Michael Russell, Wu, H.-Y.. Nasal-associated lymphoid tissue and mucosal vaccine development Mucosal Immunology Update. 1997; 5.
  • Russell M, Wu, H.-Y., Hajishengallis, G., Harokopakis, E., Toida, N., Hollingshead, S.K., Michalek, S.M.. Genetically engineered cellular and molecular vaccines: chimeric immunogens based on cholera toxin and their delivery in a Salmonella vector. Mucosal Solutions: Advances in Mucosal Immunology.. 1997; 2.
  • Toida N, Hajishengallis G, Wu HY, Michael Russell. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues. Infect Immun. 1997; 65(3).
  • Wu H-Y, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res. 1997; 16.
  • Wu HY, Nahm MH, Guo Y, Michael Russell, Briles DE. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis. 1997; 175(4).
  • Wu HY, Nguyen HH, Michael Russell. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol. 1997; 46(5).
  • Wu HY, Nikolova EB, Beagley KW, Eldridge JH, Russell MW, M. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization. Infect Immun. 1997; 65(1).
  • Wu HY, Virolainen A, Mathews B, King J, Michael Russell, Briles DE. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog. 1997; 23(3).
  • Wu, H.-Y., Nikolova, E.B., Beagley, K.W., Eldridge, J.H., Michael Russell. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization Infect. Immun.. 1997; 65.
  • Briles DE, Tart RC, Wu HY, Ralph BA, Russell MW, McDaniel LS, M. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann N Y Acad Sci. 1996; 797.
  • Hajishengallis G, Harokopakis E, Hollingshead SK, Russell MW, Michalek SM. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin. Vaccine. 1996; 14(16).
  • Hajishengallis G, Michalek SM, Russell MW. Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect Immun. 1996; 64(2).
  • Hajishengallis, G., Harokopakis, E., Hollingshead, S.K., Michael Russell, Michalek, S.M.. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin Vaccine. 1996; 14.
  • Hajishengallis, G., Michalek, S.M., Michael Russell. Persistence of serum and salivary antibody responses afer oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin Infect. Immun.. 1996; 64.
  • Hedges SR, Blalock C, Kallman L, Mayo MS, Smith K, Mestecky J, Hook E, Russell MW. Infection with Neisseria gonorrhoeae induces acute systemic, but not local, immune and inflammatory responses: effects of concomitant infection with Trichomonas vaginalis and Chlamydia trachomatis. Pathogenic Neisseria. 1996.
  • Michael Russell, Moldoveanu, Z., White, P.L., Sibert, G.J., Mestecky, J., Michalek, S.M.. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit Infect. Immun.. 1996; 64.
  • Michael Russell, Wu, H.-Y., Hajishengallis, G., Harokopakis, E., Briles, D.E., Michalek, S.M., Mestecky, J.. IgA antibodies and mucosal immune protection Period. Biolog.. 1996; 98.
  • Michalek SM, Hajishengallis G, Redman TK, Harokopakis E, Russell MW. Mucosal antigen delivery systems/adjuvants for inducing protective immunity against mutans streptococci. Germfree Life and Its Ramifications. 1996.
  • Michalek, S.M., Hajishengallis, G., Redman, T.K., Harokopakis, E., Michael Russell. Mucosal antigen delivery systems/adjuvants for inducing protective immunity against mutans streptococci Germfree Life and Its Ramifications. 1996.
  • Russell MW. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunit. Mucosal Immunization. 1996.
  • Russell MW, Hajishengallis G, Wu H-Y, Hollingshead SK, Briles DE, Moldoveanu Z, Michalek SM, Mestecky J. Recombinant CTB-linked immunogens for inducing antibodies in secretions. Pathogenic Neisseria. 1996.
  • Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek S M, M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun. 1996; 64(4).
  • Russell MW, Wu H-Y, Hajishengallis G, Harokopakis E, Briles DE, Michalek SM, Mestecky J. IgA antibodies and mucosal immune protection. Period Biolog. 1996; 98.
  • Wu HY, Nikolova EB, Beagley KW, Russell MW, M. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology. 1996; 88(4).
  • Hajishengallis G, Hollingshead SK, Koga T, Russell MW. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol. 1995; 154(9).
  • Katz J, Russell MW, Harmon CC, Buckner G, White P, Richardson GJ, Michalek SM. Induction of salivary IgA responses to S. mutans Ag I/II after intranasal immunization. Adv Exp Med Biol. 1995; 371B.
  • Mestecky J, Russell MW, Jackson S, Michalek SM, Tlaskalova H, Sterzl J. Advances in mucosal immunology. Advances in Experimental Medicine and Biology. 1995.
  • Mestecky J, Russell MW, Kilian M. The potential role of IgA-mediated mucosal immunity in the prevention of hypersensitivity reactions in the respiratory tract. Prog Allergy Clin Immunol. 1995; 3.
  • Mestecky, J., Russell M. J chain Human Protein Data (3rd Installment). 1995.
  • Michael Russell, Harrington, D.J., Russell, R.R.B.. Identity of Streptococcus mutans surface protein antigen III and wall-associated protein antigen A Infect. Immun.. 1995; 63.
  • Michael Russell, Mestecky, J.. Secretory component Human Protein Data. 1995; 3.
  • Michalek SM, Lackner A, Katz J, Russell MW, Eldridge JH, Mestecky J, Lallone R, Moldoveanu Z. Oral immunization studies with Streptococcus mutans and influenza vaccines in rhesus macaque monkeys. Adv Exp Med Biol. 1995; 371(B).
  • Michalek, S.M., Lackner, A., Katz, J., Michael Russell, Eldridge, J.H., Mestecky, J., Lallone, R., Moldoveanu, Z.. Oral immunization studies with Streptococcus mutans and influenza vaccines in rhesus macaque monkeys Adv. Exp. Med. Biol.. 1995; 371B.
  • Moldoveanu Z, Russell MW, Wu H-Y, Huang W-Q, Compans RW, Mestecky J. Compartmentalization within the mucosal immune system. Adv Exp Med Biol. 1995; 371A.
  • Nikolova EB, Russell MW, M. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J Leukoc Biol. 1995; 57(6).
  • Russell M, Mestecky, J.. Secretory component. Human Protein Data (3rd Installment).. 1995.
  • Russell MW, Harrington DJ, Russell RR, M. Identity of Streptococcus mutans surface protein antigen III and wall-associated protein antigen A. Infect Immun. 1995; 63(2).
  • Wu H-Y, White PL, Beagley KW, Jackson GDF, Mestecky J, Russell MW. IgA production and transport in the murine liver after mucosal immunization. Adv Exp Med Biol. 1995; 371B.
  • Hajishengallis G, Koga T, Russell MW. Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res. 1994; 73(9).
  • Kilian M, Russell MW. Function of mucosal immunoglobulins. Handbook of Mucosal Immunology. 1994.
  • Nikolova EB, Tomana M, Russell MW, M. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Scand J Immunol. 1994; 39(3).
  • Nikolova EB, Tomana M, Russell MW, M. The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Immunology. 1994; 82(2).
  • Nikolova, E.B., Tomana, M., Michael Russell. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone Scand. J. Immunol.. 1994; 39.
  • Nikolova, E.B., Tomana, M., Michael Russell. The role of carbohydrate chains in complement (C3) fixation by solid-phase bound human IgA Immunology. 1994; 82.
  • Taudorf E, Møller C, Russell MW, M. Secretory IgA response in oral immunotherapy. Investigation in birch pollinosis. Allergy. 1994; 49(9).
  • Wu, H-Y, Russell M. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity. Vaccine. 1994; 12.
  • Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM, M. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun. 1993; 61(5).
  • Menge AC, Michalek SM, Russell MW, Mestecky J, M. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun. 1993; 61(5).
  • Wu HY, Russell MW, M. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 1993; 61(1).
  • Hajishengallis G, Nikolova E, Russell MW. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage. Infect Immun. 1992; 60(12).
  • Mestecky, J., Russell M. Immunoglobulin A. Human Protein Data (1st Installment).. 1992.
  • Michael Russell. Immunization against dental caries Curr. Opin. Dent.. 1992; 2.
  • Michael Russell, Lue, C., van den Wall Bake, A.W.L., Moldoveanu, Z., Mestecky, J.. Molecular heterogeneity of human IgA antibodies during an immune response Clin. Exp. Immunol.. 1992; 87.
  • Michael Russell, Wu, H.-Y., White, P.L., Kilian, M., Henrichsen, J.. Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci Oral Microbiol. Immunol.. 1992; 7.
  • Michalek SM, Childers NK, Katz J, Dertzbaugh M, Russell MW. Use of liposomes for the induction of mucosal immunity. Vaccine Res. 1992; 1.
  • Michalek SM, Childers NK, Katz J, Dertzbaugh M, Zhang S, Russell MW, Macrina FL, Jackson S, Mestecky J. Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses. In: Genetically Engineered Vaccines. Adv Exp Med Biol. 1992; 327.
  • Michalek, S.M., Childers, N.K., Katz, J., Dertzbough, M., Michael Russell. Use of liposomes for the induction of mucosal immunity Vaccine Res.. 1992; 1.
  • Russell MW, Lue C, van den Wall Bake AW, Moldoveanu Z, Mestecky J, M. Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol. 1992; 87(1).
  • Russell MW, M. Immunization against dental caries. Curr Opin Dent. 1992; 2.
  • Russell MW, Wu H-Y, White PL, Takahashi I, Okahashi N, Koga T. Peroral immunization with a cholera toxin-linked bacterial protein antigen and synthetic peptide. In: Genetically Engineered Vaccines. Adv Exp Med Biol. 1992; 327.
  • Russell MW, Wu HY, White PL, Kilian M, Henrichsen J, M. Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci. Oral Microbiol Immunol. 1992; 7(6).
  • Takahashi I, Matsushita K, Nisizawa T, Okahashi N, Russell MW, Suzuki Y, Munekata E, Koga T, M. Genetic control of immune responses in mice to synthetic peptides of a Streptococcus mutans surface protein antigen. Infect Immun. 1992; 60(2).
  • Wu HY, Russell MW, M. Antibody-secreting cell responses in the mouse liver. Immunology. 1992; 77(3).
  • Mestecky J, Lue C, Russell MW, M. Selective transport of IgA. Cellular and molecular aspects. Gastroenterol Clin North Am. 1991; 20(3).
  • Michael Russell, Wu, H.-Y.. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to cholera toxin B subunit Infect. Immun.. 1991; 59.
  • Michalek, S.M., Katz, J., Childers, N.K., Moldoveanu, Z., Russell M, Jackson, S., Dertzbaugh, M., Mestecky, J.. Characteristics of oral Streptococcus mutans vaccines important for the induction of mucosal immune responses in rats. Frontiers of Mucosal Immunology.. 1991; 1.
  • Russell MW, Wu HY, M. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun. 1991; 59(11).
  • Takahashi I, Okahashi N, Matsushita K, Tokuda M, Kanamoto T, Munekata E, Russell MW, Koga T, M. Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol. 1991; 146(1).
  • Heck LW, Alarcon PG, Kulhavy RM, Morihara K, Russell MW, Mestecky JF, M. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J Immunol. 1990; 144(6).
  • Mestecky J, Lue C, Tarkowski A, Moldoveanu Z, Czerkinsky C, Ladjeva I, Peterman JH, Russell MW, Kiyono H, McGhee JR. Induction of human secretory and serum immune responses; molecular properties of IgA antibodies. Advances in Mucosal Immunology. 1990.
  • Mestecky J, Waldo FB, Britt WJ, Julian BA, Tomana M, van den Wall Bake AWI, Russell MW, Galla JH, Moldoveanu Z, Jackson S. Exogenous antigens deposited in the glomeruli of patients with IgA nephropathy. Pathogenesis of IgA Nephropathy. 1990.
  • Michael Russell, Prince, S.J., Ligthart, G.J., Mestecky, J., Radl, J.. Comparison of salivary and serum antibodies to common environmental antigens in elderly, edentulous, and normal adult subjects Aging Immunol. Infect. Dis.. 1990; 2.
  • Michael Russell, Wu, H.. Streptococcus mutans and the problem of heart cross-reactivity Crit. Rev. Oral Biol. Med.. 1990; 1.
  • Russell MW, Mansa B, Reinholdt J, Killian M. Inhibition of complement activation by human IgA antibodies and their Fab fragments. Advances in Mucosal Immunology. 1990.
  • Russell MW, Prince SJ, Ligthart GJ, Mestecky J, Radl J. Comparison of salivary and serum antibodies to common environmental antigens in elderly, edentulous, and normal adult subjects. Aging Immunol Infect Dis. 1990; 2.
  • Russell MW, Wu H. Streptococcus mutans and the problem of heart cross-reactivity. Crit Rev Oral Biol Med. 1990; 1.
  • Wu HY, Russell MW, M. Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments. Infect Immun. 1990; 58(11).
  • Czerkinsky C, Russell MW, Lycke N, Lindblad M, Holmgren J, M. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun. 1989; 57(4).
  • Mestecky J, Lue C, Tarkowski A, Ladjeva I, Peterman J, Moldoveanu Z, Russell MW, Brown TA, Radl J, Haaijman JJ, Kiyono H, McGhee JR. Comparative studies of the biological properties of human IgA subclasses. Protides Biol Fluids. 1989; 36.
  • Michael Russell, Kilian, M., Reinholdt, J., Mansa, B.. Significance of Fab fragments of IgA1 antibodies in bacterial evasion of host defense mechanisms Protides Biol. Fluids. 1989; 36.
  • Michael Russell, Mansa, B.. Complement-fixing properties of human IgA antibodies: alternative pathway complement and activation by plastic-bound, but not by specific antigen-bound IgA Scand. J. Immunol.. 1989; 30.
  • Michael Russell, Mansson-Rahemtulla, B.. Interaction between surface protein antigens of Streptococcus mutans and human salivary components Oral Microbiol. Immunol.. 1989; 4.
  • Michael Russell, Prince, S.J., Ligthart, G.J., Radl, J., Mestecky, J.. Serum and salivary IgA1, IgA2, IgG, and IgM antibodies to bacterial antigens in aged, edentulous, and normal adults Protides Biol. Fluids. 1989; 36.
  • Michael Russell, Reinholdt, J., Kilian, M.. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation Eur. J. Immunol.. 1989; 19.
  • Russell MW, Kilian M, Reinholdt J, Mansa B. Significance of Fab fragments of IgA1 antibodies in bacterial evasion of host defense mechanisms. Protides Biol Fluids. 1989; 36.
  • Russell MW, Mansa B, M. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA. Scand J Immunol. 1989; 30(2).
  • Russell MW, Mansson-Rahemtulla B, M. Interaction between surface protein antigens of Streptococcus mutans and human salivary components. Oral Microbiol Immunol. 1989; 4(2).
  • Russell MW, Prince SJ, Ligthart GJ, Radl J, Mestecky J. Serum and salivary IgA1, IgA2, IgG, and IgM antibodies to bacterial antigens in aged, edentulous, and normal adults. Protides Biol Fluids. 1989; 36.
  • Russell MW, Reinholdt J, Kilian M, M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur J Immunol. 1989; 19(12).
  • Kilian M, Mestecky J, Russell MW, M. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev. 1988; 52(2).
  • Mestecky, J., Moldoveanu, Z., Komiyama, K., Tomana, M., Phillips, J.O., Russell M, Brown, T.A., Crago, S.S., Moro, I.. Interaction of IgA with non-lymphoid cells. Mucosal Immunity and Infection at Mucosal Surfaces.. 1988.
  • Michael Russell, Mestecky, J.. Induction of the mucosal immune response Rev. Infect. Dis.. 1988; 10(2).
  • Phillips JO, Komiyama K, Epps JM, Russell MW, Mestecky J, M. Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice. Mol Immunol. 1988; 25(9).
  • Russell MW, Mestecky J. Induction of the mucosal immune response. Rev Infect Dis. 1988; 10(2).
  • Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Moldoveanu Z, Russell MW, McGhee JR, Mestecky J. Oral immunization with bacterial antigen induces IgA-secreting cells in peripheral blood in humans. Adv Exp Biol Med. 1987; 216(B).
  • Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, McGhee JR, Mestecky J, M. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A. 1987; 84(8).
  • Czerkinsky, C., Prince, S.J., Michalek, S.M., Jackson, S., Moldoveanu, Z., Michael Russell, McGhee, J.R., Mestecky, J.. Oral immunization with bacterial antigen induces IgA-secreting cells in peripheral blood in humans Adv. Exp. Biol. Med.. 1987; 216(B).
  • Julian BA, Czerkinsky C, Russell MW, Galla JH, Koopman WJ, Mestecky J, Moldoveanu Z, Jackson S, M. Striking elevation of serum IgA, IgA-containing immune complexes, and IgA rheumatoid factor in clinically silent dermatitis herpetiformis. Am J Kidney Dis. 1987; 10(5).
  • Mestecky J, Czerkinsky C, Russell MW, Brown TA, Prince SJ, Moldoveanu Z, Jackson S, Michalek SM, McGhee JR, M. Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens. Ann Allergy. 1987; 59(5 Pt).
  • Mestecky J, Tomana M, Czerkinsky C, Tarkowski A, Matsuda S, Waldo FB, Moldoveanu Z, Julian BA, Galla JH, Russell MW, M. IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions. Semin Nephrol. 1987; 7(4).
  • Mestecky, J., Czerkinsky, C., Michael Russell, Brown, T.A., Prince, S.J., Moldoveanu, Z., Jackson, S., Michalek, S.M., McGhee, J.R.. Induction and properties of secretory and serum IgA antibodies specific for environmental antigens Ann. Allergy. 1987; 59.
  • Mestecky, J., Tomana, M., Czerkinsky, C., Tarkowski, A., Matsuda, S., Waldo, F.B., Moldoveanu, Z., Julian, B.A., Galla, J.H., Michael Russell, Jackson, S.. IgA-Associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions Sem. Nephrol.. 1987; 7.
  • Michael Russell. Analysis of heart-reactive antibodies induced in rabbits by immunization with Streptococcus mutans J. Oral Path.. 1987; 16.
  • Michael Russell, Spotswood, M.F., Julian, B.A., Galla, J.H., Mestecky, J.. Detection of food antigen-specific immune complexes in human sera Adv. Exp. Med. Biol.. 1987; 84.
  • Russell MW, M. Analysis of heart-reactive antibodies induced in rabbits by immunization with Streptococcus mutans. J Oral Pathol. 1987; 16(5).
  • Russell MW, Spotswood MF, Julian BA, Galla JH, Mestecky J. Detection of food antigen-specific immune complexes in human sera. Adv Exp Med Biol. 1987; 216(A).
  • Mestecky J, Russell MW, Jackson S, Brown TA, M. The human IgA system: a reassessment. Clin Immunol Immunopathol. 1986; 40(1).
  • Mestecky, J, Russell M. IgA subclasses. Monogr Allergy. 1986; 19.
  • Mestecky, J., Czerkinsky, C., Brown, T.A, Michalek, S.M., Russell M, Jackson, S., Scholler, M., McGhee, R.. Human immune response to Streptococcus mutans. Molecular Microbiology and Immunobiology of Streptococcus mutans.. 1986.
  • Mestecky, J., Michael Russell, Jackson, S., Brown, T.A.. The human IgA system: a reassessment Clin. Immunol. Immunopath.. 1986; 40.
  • Michael Russell, Brown, T.A., Radl, J., Haaijman, J.J., Mestecky, J.. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies J. Immunol. Methods. 1986; 87.
  • Michael Russell, Czerkinsky, C., Moldoveanu, Z.. Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans Infect. Immun.. 1986; 53.
  • Michael Russell, Mestecky, J.. Potential for immune intervention against dental caries J. Biol. Buccale. 1986; 14.
  • Michael Russell, Mestecky, J., Julian, B.A., Galla, J.H.. Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli J. Clin. Immunol.. 1986; 6.
  • Phillips JO, Stohrer R, Russell MW, Brown TA, Epps JM, Kearney JF, Mestecky J, M. Analysis of the hepatobiliary transport of IgA with monoclonal anti-idiotype and anti-allotype antibodies. Mol Immunol. 1986; 23(3).
  • Russell M. Protein antigens of Streptococcus mutans. Molecular Microbiology and Immunbiology of Streptococcus mutans.. 1986.
  • Russell MW, Brown TA, Phillips JO. Contribution of hepatobiliary transport of IgA to disposal of bacterial antigenic products. Bacteria and the Host.. 1986.
  • Russell MW, Brown TA, Radl J, Haaijman JJ, Mestecky J, M. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods. 1986; 87(1).
  • Russell MW, Czerkinsky C, Moldoveanu Z, M. Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans. Infect Immun. 1986; 53(2).
  • Russell MW, Mestecky J, Julian BA, Galla JH, M. IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J Clin Immunol. 1986; 6(1).
  • Russell MW, Mestecky J, M. Potential for immunological intervention against dental caries. J Biol Buccale. 1986; 14(3).
  • Mestecky J, McGhee JR, Russell MW, Michalek SM, Kutteh WH, Gregory RL, Scholler-Guinard M, Brown TA, Crago SS. Evidence for a common mucosal immune system in humans. Prot Biol Fluids. 1985; 32.
  • Mestecky J, Russell MW, Jackson W, Julian BA, Galla JH. Immunological studies on IgA-associated renal diseases. Mucosal Immunity. IgA and Polymorphonuclear Neutrophils. 1985.
  • Michael Russell, Hammond, D., Radl, J., Haaijman, J.J., Mestecky, J.. Secretory IgA1 and IgA2 responses to environmental antigens Prot. Biol. Fluids. 1985; 32.
  • Brown TA, Russell MW, Mestecky J, M. Elimination of intestinally absorbed antigen into the bile by IgA. J Immunol. 1984; 132(2).
  • Phillips JO, Russell MW, Brown TA, Mestecky J, M. Selective hepatobiliary transport of human polymeric IgA in mice. Mol Immunol. 1984; 21(10).
  • Brown TA, Russell MW, Kulhavy R, Mestecky J, M. IgA-mediated elimination of antigens by the hepatobiliary route. Fed Proc. 1983; 42(15).
  • Mestecky J, Kutteh WH, Brown TA, Russell MW, Phillips JO, Moldoveanu Z, Moro I, Crago SS, M. Function and biosynthesis of polymeric IgA. Ann N Y Acad Sci. 1983; 409.
  • Mestecky, J., Kutteh, W.H., Brown,T.A., Michael Russell, Phillips, J.O., Moldoveanu, Z., Moro, I., Crago, S.S.. Function and biosynthesis of polymeric IgA Ann. N.Y. Acad. Sci.. 1983; 409.
  • Michael Russell, Brown, T.A., Claflin, J.L., Schroer, K., Mestecky, J.. IgA-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens Infect. Immun.. 1983; 42.
  • Michael Russell, Brown,T.A., Kulhavy, R., Mestecky, J.. IgA-mediated hepatobiliary clearance of bacterial antigens Ann. N.Y. Acad. Sci.. 1983; 409.
  • Moro I, Russell MW, M. Ultrastructural localization of protein antigens I/II and III in Streptococcus mutans. Infect Immun. 1983; 41(1).
  • Phillips JO, Russell MW, Brown TA, Mestecky J. Selective hepatobiliary transport of monoclonal IgG but not IgM anti-idiotypic antibodies by IgA. Ann NY Acad Sci. 1983; 409.
  • Russell MW, Brown TA, Claflin JL, Schroer K, Mestecky J, M. Immunoglobulin A-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens. Infect Immun. 1983; 42(3).
  • Russell MW, Brown TA, Kulhavy R, Mestecky J. IgA-mediated hepatobiliary clearance of bacterial antigens. Ann N Y Acad Sci. 1983; 409.
  • Brown TA, Russell MW, Mestecky J, M. Hepatobiliary transport of IgA immune complexes: molecular and cellular aspects. J Immunol. 1982; 128(5).
  • Metescky J, Kutteh W, Cargo SS, Laven GT, Brown TA, Russell MW, Moldoveanu Z. Cellular and humoral pathways in the IgA mucosal system. Recent Advances in Mucosal Immunity. 1982.
  • Michael Russell, Brown, T.A., Mestecky, J.. Preferential transport of IgA and IgA immune complexes to bile compared with other secretions Molec. Immunol.. 1982; 19.
  • Lehner T, Russell MW, Caldwell J, Smith R, M. Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect Immun. 1981; 34(2).
  • Michael Russell, Brown, T.A., Mestecky, J.. Role of serum IgA: Hepatobiliary transport of circulating antigen J. Exp. Med.. 1981; 153.
  • Lehner T, Russell MW, Caldwell J, Russell M. Immunization with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet. 1980; 1(8176).
  • Lehner, T., Michael Russell, Caldwell, J.. Immunization with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys Lancet. 1980; i.
  • Michael Russell, Bergmeier, L.A., Zanders, E.D., Lehner, T.. Protein antigens of Streptococcus mutans: Purification and properties of a double antigen and its protease-resistant component Infect. Immun.. 1980; 28.
  • Michael Russell, Challacombe, S.J., Lehner, T.. Specificity of antibodies induced by Streptococcus mutans during immunization against dental caries Immunology. 1980; 40.
  • Michael Russell, Zanders, E.D., Bergmeier, L.A., Lehner, T.. Affinity purification and characterization of the protease-susceptible antigen I of Streptococcus mutans Infect. Immun.. 1980; 29.
  • Russell M, Challacombe, SJ, Lehner, T. Specificity of antibodies induced by Streptococcus mutans during immunization against dental caries. Immunology. 1980; 40.
  • Russell MW, Bergmeier LA, Zanders ED, Lehner T, M. Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun. 1980; 28(2).
  • Russell MW, Zanders ED, Bergmeier LA, Lehner T, M. Affinity purification and characterization of protease-susceptible antigen I of Streptococcus mutans. Infect Immun. 1980; 29(3).
  • Scully CM, Russell MW, Lehner T, M. Specificity of opsonizing antibodies to antigens of Streptococcus mutans. Immunology. 1980; 41(2).
  • Challacombe SJ, Russell MW, M. Estimation of the intravascular half-lives of normal rhesus monkey IgG, IgA and IgM. Immunology. 1979; 36(2).
  • Lehner T, Russell MW, Scully SM. The role of IgG, IgM, and IgA classes of antibodies to Streptococcus mutans in protection against caries in rhesus monkeys. Pathogenic Streptococci. 1979.
  • Michael Russell. Purification and properties of a protein surface antigen of Streptococcus mutans Microbios. 1979; 25.
  • Russell MW, Caldwell J, Lehner T. Antibody response to Streptococcus mutans antigens during immunization against dental caries. Pathogenic Streptococci. 1979.
  • Challacombe SJ, Russell MW, Hawkes J, M. Passage of intact IgG from plasma to the oral cavity via crevicular fluid. Clin Exp Immunol. 1978; 34(3).
  • Challacombe SJ, Russell MW, Hawkes JE, Bergmeier LA, Lehner T, M. Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology. 1978; 35(6).
  • Challacombe, S.J., Michael Russell, Hawkes, J.E.. Passage of intact IgG from plasma to the oral cavity via crevicular fluid Clin. Exp. Immunol.. 1978; 34.
  • Challacombe, S.J., Michael Russell, Hawkes, J.E., Bergmeier, L.A., Lehner, T.. Passage of immunoglobulilns from plasma to the oral cavity in rhesus monkeys Immunology. 1978; 35.
  • Lehner T, Russell MW, Challacombe SJ, Scully CM, Hawkes JE, M. Passive immunization with serum and immunoglobulins against dental caries in rhesus monkeys. Lancet. 1978; 1(8066).
  • Lehner, T., Michael Russell, Challacombe, S.J., Wilton, J.M.A., Scully, C.M., Hawkes, J.E.. Passive immunization with serum and immunoglobulins against dental caries in rhesus monkeys Lancet. 1978; i.
  • Lehner, T., Michael Russell, Wilton, J.M.A., Challacombe, S.J., Scully, C.M., Hawkes, J.E.. Passive immunization with antisera to Streptococcus mutans in the prevention of caries in rhesus monkeys Adv. Exp. Med. Biol.. 1978; 107.
  • Michael Russell, Lehner, T.. Characterization of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Archs. Oral Biol.. 1978; 23.
  • Michael Russell, Brooker, B.E., Reiter, B.. Electron microscopic observations of the interaction ofcasein micelles and milk fat globules with bovine polymorphonuclear leukocytes during the phagocytosis of staphylococci in milk J. Comp. Pathol.. 1977; 87.
  • Michael Russell, Brooker, B.E., Reiter, B.. Inhibition of the bactericidal activity of bovine polymorphonuclear leucocytes and related systems by casein Res. Vet. Sci.. 1976; 20.
  • Michael Russell, Challacombe, S.J., Lehner, T.. Serum glucosyltransferase-inhibiting antibodies and dental caries in rhesus monkeys immunized againsts Streptococcus mutans Immunology. 1976; 30.
  • Russell MW, Brooker BE, Reiter B, M. Inhibition of the bactericidal activity of bovine polymorphonuclear leucocytes and related systems by casein. Res Vet Sci. 1976; 20(1).
  • Russell MW, Challacombe SJ, Lehner T, M. Serum glucosyltransferase-inhibiting antibodies and dental caries in rhesus monkeys immunized against Streptococcus mutans. Immunology. 1976; 30(5).
  • Michael Russell, Reiter, B.. Phagocytic deficiency of bovine milk leukocytes: An effect of casein J. Reticuloendothelial. Soc.. 1975; 18.
See All (258 Total) >

Abstracts:
  • Feinen B, Gaffen S, Jerse AE, Russell MW. Role of Th17 responses in genital tract infection with Neisseria gonorrhoeae. 14th International Congress of Mucosal Immunology. 2009.
  • Zhao W, Zhao Z, Metzger DJ, Connell TD, Russell MW. Adjuvant mechanisms of recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens. 14th International Congress of Mucosal Immunology. 2009.
  • Feinen B, Gaffen S, Jerse AE, Russell MW. IL-17 elicits a neutrophil-attractant response to Neisseria gonorrhoeae infection. AAI. 2009.
  • Feinen B, Gaffen S, Jerse AE, Russell MW. Neisseria gonorrhoeae induces IL-22, a Th17 cytokine involved in mucosal humoral defense. ASM. 2009.
  • Feinen B, Jerse AE, Gaffen S, Russell MW. Neisseria gonorrhoeae elicits IL-17-dependent responses in a murine model of genital tract infection. Keystone Symposium on TH17 Cells in Health and Disease. 2009.
  • Mestecky J, Moldoveanu Z, Russell MW, Elson CO. Mucosal tolerance and vaccines. Modern Mucosal Vaccines, Adjuvants & Microbicides. 2008.
  • Russell M, Feinen, B, Jerse, AE, Gaffen S. The Th17 axis of immunity: a new dimension in comprehending the host response to Neisseria gonorrhoeae.. International Pathogenic Neisseria Conference, Rotterdam, The Netherlands. 2008.
  • Feinen, B, Jerse, AE, Gaffen S, Russell M. Neisseria gonorrhoeae induces a Th17 response.. ASM. 2008.
  • Ostberg KL, Russell MW, Murphy TF. Mucosal immunization of mice with recombinant P2 of nontypeable Haemophilus influenzae induces antibodies that recognize multiple strains.. American Association for Laboratory Animal Science, Upstate NY Branch Mtg. 2008.
  • Feinen B, Jerse AE, Russell MW. Proinflammatory cytokine response of murine and human mononuclear cells to Neisseria gonorrhoeae.. Upstate New York Immunology Conference. 2007.
  • Mestecky J, Moldoveanu Z, Russell MW. Immunological uniqueness of the male genital tract: humoral responses to local infections and systemic and mucosal immunizations.. IIIrd National Congress of Andrology. 2007.
  • Feinen, B, Jerse, AE, Russell M. Proinflammatory cytokine response of murine and human mononuclear cells to Neisseria gonorrhoeae.. ASM. 2007.
  • Ostberg, KL, Russell M, Murphy, TF. Recombinant OMP P2 of nontypeable Haemophilus influenzae is immunogenic when administered mucosally.. ASM. 2007.
  • Russell M. Immunoglobulins and antibody responses within genital secretions reveal the immunological uniqueness of the genital mucosae.. Am J Reproduct Immunol. 2007; 57.
  • Liang S, Wang M, Nawar H, Russell M, Connell T, Hajishengallis G. Caries Vaccine Adjuvants, Toll-like-receptors (TLRs), and Mechanisms of Cell Activation. J Dent Res. 2007.
  • Russell MW, Arce S, Nawar HF, Hajishengallis G. Novel mechanisms of immunodulatory activity by type I and type II enterotoxins.. 5th Mtg. of the European Mucosal Immunology Group. 2006.
  • Jerse AE, Russell MW, Veit SJ, Begum AA, Wu H. Sialylation plays a detectable role in protecting Neisseria gonorrhoeae from bactericidal antibodies induced by immunization in vitro but not in vivo.. 15th International Pathogenic Neisseria Conference. 2006.
  • Russell MW, Connell T, Tapping,RI, Hajishengallis G. Novel mechanisms of immunomodulatory activity by type II enterotoxins depend on Toll-like receptor 2.. 8th Annual Upstate New York Immunology Conference. 2005.
  • Nawar H, Arce S, Getman K, Berenson C, Russell MW. Immunomodulatory activities of LT-IIa and LT-IIb enterotoxin adjuvants depend upon binding to surface receptors other than ganglioside GM1.. 8th Annual Upstate New York Immunology Conference. 2005.
  • Russell MW, Connell TD, Tapping RI, Hajishengallis G. Novel mechanisms of immunomodulatory activity by type II enterotoxins depend on toll-like receptor 2.. 12th International Congress of Mucosal Immunology. 2005.
  • Gockel CM, Nugent RJ, Russell MW. Induction and recall of immune memory to AgI/II by mucosal immunization with SBR-CTA2/B chimeric immunogen.. 12th International Congress of Mucosal Immunology. 2005.
  • Nawar H, Arce S, Russell MW, Connell TD. Immunomodulatory activities of LT-IIa and LT-IIb enterotoxin adjuvants depend upon binding to surface receptors other than ganglioside GM1.. 12th International Congress of Mucosal Immunology. 2005.
  • Arce S, Nawar HF, Russell MW, Connell TD. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.. 12th International Congress of Mucosal Immunology. 2005.
  • Harokopakis E, Martin MH, Russell MW, Hajishengallis G. Inflammatory interactions of P. gingivalis with toll-like receptors.. 8th European Oral Microbiology Workshop. 2005.
  • Price GA, Russell MW, Cornelissen CN. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.. 14th International Pathogenic Neisseria Conference. 2004.
  • Russell MW. Mucosal adjuvants, carriers, and vaccination platforms amenable to mass immunization in event of bio-emergency.. Northeast Biodefense Center Annual Meeting. 2004.
  • Nawar, HF, Arce, S, Russell M, Connell T. Examination of the role of ganglioside receptor binding in the adjuvant activities of the type II heat-labile enterotoxins LT-IIa and LT-IIb by use of receptor-binding mutants.. ASM. 2004.
  • McMahon, M, Connell T, Russell M, Thanavala, Y. Comparison of the adjuvant properties of the mucosal adjuvants CT, LT-IIa and LT-IIb when delivered with P6, a poorly immunogenic outer membrane protein from nontypeable Haemophilus influenzae.. ASM. 2004.
  • Gockel C, Nugent R, Russell MW. Inducing and recalling immune memory to AgI/II by mucosal immunization. J Dent Res. 2004.
  • Gockel C, Nugent R, Russell MW. Inducing and recalling immune memory to AgI/II by mucosal immunization.. Upstate New York Immunology Conference. 2003.
  • Russell MW, Childers NK, Michalek SM, Smith DJ, Taubmann MA. A caries vaccine? European Organization for Caries Research (ORCA) symposium on Cariology in the 21st Century.. State of the Art and Future Perspectives. 2003.
  • Mestecky J, Moldoveanu Z, Pate M, Russell MW. Induction of immune response in human female and male reproductive tract.. 4th Congress of the European Society for Reproductive Immunology. 2003.
  • Guerrero Manriquez GG, Russell MW, Hernandez Teran F, Moreno-Fierros L. Systemic and mucosal adjuvant properties of Cry protoxins and toxins in mice results from the differential induction of the Th1/Th2 responses.. 3rd Annual Mtg., Federation of Clinical Immunology Societies. 2003.
  • Russell MW, Hedges SR, Sibley DA, Dvorakova K, McNamara S, Metzger D. The failure of protective immunity against genital infection with Neisseria gonorrhoeae is twofold.. 13th International Pathogenic Neisseria Conference. 2002.
  • Russell MW, Hedges SR, Sibley DA, Dvorakova K, McNamara S, Metzger D. Studies on the lack of protective immunity against genital infection with Neisseria gonorrhoeae.. 11th International Congress of Mucosal Immunology. 2002.
  • Russell MW, Hedges SR, Hobbs MM, Cohen MS. Analysis of genital immune responses in males with gonococcal urethritis.. 11th International Congress of Mucosal Immunology. 2002.
  • Hajishengallis, G, Sojar, HT, Russell M, Genco RJ. Down regulation of the p65 subunit of NF-kB induces monocytic cell hyporesponsiveness to secondary stimulation with P. gingivalis FimA.. ASM. 2002.
  • Mestecky, J, Moldoveanu, Z, Russell M. How "common" is the common mucosal immune system and its individual compartments? Implications for vaccine development.. New Approaches to Bacterial Vaccine Development, Munrich, Germany. 2002.
  • Hajishengallis G, Martin M, Sojar HT, Sharma A, DeNardin E, Russell MW, Genco RJ. Proinflammatory cytokine induction by bacterial protein adhesins via activation of the CD14-TLR2/4.. AAI. 2001.
  • Russell MW, Hedges SR, Sibley DA, Mayo MS, Mestecky J, Hook EW. The paucity of mucosal immune responses in human gonorrhea favors vaccine development.. 12th International Pathogenic Neisseria Conference. 2000.
  • Mestecky J, Moldoveanu Z, Russell MW. Mucosal immune system of the human genital tract.. 3rd Congress of the European Society for Reproductive and Developmental Immunology. 2000.
  • Hajishengallis G, Harokopakis E, Michalek SM, Russell MW. Prevention of dental caries by intervention in the colonization of tooth surfaces by Streptococcus mutans.. 10th Pan-Cretan Stomatologic Congress. 2000.
  • Harokopakis E, Hajishengallis G, Russell MW, Michalek SM. Development of a vaccine against dental caries.. 10th Pan-Cretan Stomatologic Congress. 2000.
  • Russell MW, Hedges SR, Wu H-Y, Hook EW, Mestecky J. Generation of genital immune responses by infection or vaccination.. Czech Society for Reproductive Immunology. 2000.
  • Sibley, DA, Thon, V, Shewbert, S, Russell M. Altered accessory cell function in PBMC from adult periodontitis patients.. ASM. 2000.
  • Vu HL, Troubetzkoy S, Nguyen HH, Russell MW, Mestecky J. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical method for data analysis.. AAI. 2000.
  • Jespersgaard C, Hajishengallis G, Russell MW, Michalek SM. Inhibition of Streptococcus mutans glucosyltransferase by a nonimmunoglobulin factor in human saliva.. J Dent Res. 2000; 79.
  • Martin M, Hajishengallis G, Metzger D, Michalek SM, Russell MW. Immunostimulatory activity of CT- and LT-IIa-based chimeric proteins.. J Dent Res. 2000; 79.
  • Mestecky J, Moldoveanu Z, Russell MW. Immunization routes for compartmentalized mucosal immune responses.. Keynote Symposium on "Innate and acquired immunity at mucosal surfaces",. 2000.
  • Jespersgaard, C., Hajishengallis, G., Michael Russell, Michalek, S.M.. Inhibition of Streptococcus mutans glucosyltransferase by a nonimmunoglobulin factor in human saliva. J. Dent. Res.. 2000; 79.
  • Martin, M., Hajishengallis, G., Metzger, D., Connell T, Michalek, S.M., Russell MW. Immunostimulatory activity of CT- and LT-IIa-based chimeric proteins. J. Dent. Res.. 2000.
  • Hedges SR, Mayo MS, Hook EW, Mestecky J, Russell MW. Mucosal immune responses in human gonorrhea.. Immunol Lett. 1999; 69.
  • Russell MW, Wu H-Y, Hajishengallis G, Martin MH, Michalek SM, Hollingshead SK, Connell TD, Metzger D. Mucosal vaccines based on cholera toxin B subunit.. Immunol Lett. 1999; 69.
  • Sibley DA, Hedges S, DeCarlo A, Thon V, Katz J, Russell MW. Modification of macrophage and neutrophil responses to bacteria by IgA antibodies.. Immunol Lett. 1999; 69.
  • Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW, Mestecky J. Cytokine and immunoglobulin responses in serum and urethral secretions of Chlamydia trachomatis-infected men.. Immunol Lett. 1999; 69.
  • Mestecky J, Tomana M, Novak J, Russell MW. Role of glycans in effector functions of IgA in health and disease.. Immunol Lett. 1999; 69.
  • Mestecky J, Moldoveanu Z, Pate M, Kutteh WH, Crowley-Nowick PA, Casteel LR, Kulhavy R, Prince S, Hedges S, Kantele A, Jackson S, Russell MW. Induction of mucosal immune responses in the human genital tract.. 3rd International Mtg., New Approaches to Bacterial Vaccine Development. 1999.
  • Wu, H-Y, Wu, X-P, Hollingshead, SK, Hajishengallis, G, Russell M. Importance of the link between cholera toxin (CT) A1 and A2 subunits for the stability of chimeric SBR-CT A2/B mucosal immunogens.. ASM. 1999.
  • Sibley, DA, Katz, J, Thon, V, Russell M. Porphyromonas gingivalis-specific serum antibodies from adult periodontitis patients.. ASM. 1999.
  • Jespersgaard C, Hajishengallis G, Russell MW, Michalek SM. Construction and characterization of a GTF glucan-binding domain-thoredoxin chimeric protein.. J Dent Res. 1999; 78.
  • Smith PD, Mosteller-Barnum M, Merger M, Sibley D, Russell MW, Graham M, Kubagawa H. Unique phenotype and function distinguish mucosal macrophages from blood monocytes.. Immunol Lett. 1999; 69.
  • Jespersgaard, C., Hajishengallils, G., Michael Russell, Michalek, S.M.. Construction and characterization of a GTF glucan-binding domain-thoredoxin chimeric protein. J. Dent. Res.. 1999; 78.
  • Hedges, S.R., Mayo, M.S., Hook, E.W., Mestecky, J., Michael Russell. Mucosal immune responses in human gonorrhea. Immunol. Lett.. 1999; 69.
  • Smith, P.D., Mosteller-Barum, M., Merger, M., Sibley, D., Michael Russell, Graham, M., Kubagawa, H.. Unique phenotype and function distinguish mucosal macrophages from blood monocytes. Immunol. Lett.. 1999; 69.
  • Russell MW, Wu, H.-Y., Hajishengallis, G., Martin, M.H., Michalek, S.M., Hollingshead, S.K., Connell T, Metzger, D.. Mucosal vaccines based on cholera toxin B subunit. Immunol. Lett.. 1999; 69.
  • Sibley, D.A., Hedges, S., DeCarlo, A., Thon, V., Katz, J., Michael Russell. Modification of macrophage and neutrophil responses to bacteria by IgA antibodies. Immunol. Lett.. 1999; 69.
  • Pate, M.S., Hedges, S.R., Sibley, D.A., Michael Russell, Hook, E.W., Mestecky, J.. Cytokine and immunoglobulin responses in serum and urethral secretions of Chlamydia trachomatis-infected men. Immunol. Lett.. 1999; 69.
  • Mestecky, J., Tomana, M., Novak, J., Michael Russell. Role of glycans in effector functions of IgA in health and disease. Immunol. Lett.. 1999; 69.
  • Russell MW, Hedges SR, Wu H-Y, Hook EW, Mestecky J. Mucosal immunity in the genital tract: prospects for vaccines against STDs.. Period Biol. 1998; 100(3).
  • Mestecky J, Jackson S, Moldoveanu Z, Russell MW. Induction of mucosal immune responses in the human genital tract: relevance to the development of vaccines against human immunodeficiency virus (HIV).. Period Biol. 1998; 100(3).
  • Russell MW, Singer RE, Lamster IB. Symposium: IgA and periodontal disease.. J Dent Res. 1998; 77(B).
  • Jespersgaard C, Greenway T, Smith D, Hajishengallis G, Russell MW, Michalek S. Functional characterization of two cloned regions of glucosyltransferase.. J Dent Res. 1998; 77(B).
  • Sibley, DA, Thon, V, Russell M. The role of IgA and IgG opsonizing antibodies to oral bacteria in promoting the production of cytokines by monocytes.. ASM. 1998.
  • Hedges, SR, Mayo, MS, Kallman, L, Pate, M, Mestecky, J, Hook, EW, Russell M. IgA1 protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae.. ASM. 1998.
  • Martin M, Hajishengallis G, Russell MW, Metzger D, Connell TD, Michalek SM. Purification of the recombinant protein SBR-LT-IIa2/B.. J Dent Res. 1998; 77(A).
  • Jespersgaard C, Greenway T, Smith D, Hajishengallis G, Russell MW, Michalek S. Functional characterization of two cloned regions of glucosyltransferase.. J Dent Res. 1998; 77(A).
  • Russell MW, Hedges SR, Mayo MS, Kallman L, Brandt K, Mestecky J, Hook EW. Analysis of mucosal and circulating antibody and cytokine responses in gonorrhea: Evidence for immune response evasion by Neisseria gonorrhoeae.. 11th International Pathogenic Neisseria Conference. 1998.
  • Martin, M., Hajishengallis, G., Michael Russell, Metzger, D., Terry Connell, Michalek, S.M.. Purification of the recombinant protein SBR-LT-IIa2/B. J. Dent. Res.. 1998; 77(A).
  • Jespersgaard, C., Greenway, T., Smith, D., Hajishengallis, G., Michael Russell, Michalek, S.. Functional characterization of two cloned regions of glucosyltransferase. J. Dent. Res.. 1998; 77(A).
  • Michael Russell, Singer, R.E.. Symposium: IgA and periodontal disease. J. Dent. Res.. 1998; 77(B).
  • Michael Russell, Hedges, S.R., Wu, H.-Y., Hook, E.W., Mestecky, J.. Mucosal immunity in the genital tract: prospects for vaccines against STDs. Period. Biol.. 1998; 100(3).
  • Mestecky, J., Jackson, S., Moldoveanu, Z., Michael Russell. Induction of mucosal immune responses in the human genital tract: relevance to the development of vaccines against human immunodeficiency virus (HIV). Period. Biol.. 1998; 100(3).
  • Russell MW, Wu H-Y, Hollingshead SK, Hajishengallis G. Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery.. 1st International Veterinary Vaccines and Diagnostic Conference. 1997.
  • Jespersgaard, C, Hajishengallis, G, Smith, DJ, Russell M, Michalek, SM. Construction of glucosyltransferase B-cholera toxin A2/B chimeric proteins.. ASM. 1997.
  • Harokopakis E, Hajishengallis G, Russell MW, Michalek SM. Oral immunization with avirulent S. typhimurium co-expressing S. mutans adhesin and mucosal adjuvant.. J Dent Res. 1997; 76(347).
  • Childers NK, Tong G, Russell MW, Michalek SM. Streptococcus mutans GS-5 culture supernatant contains glucosyltransferase and a truncated antigen I/II protein.. J Dent Res. 1997; 76(105).
  • Childers NK, Mitchell SC, Tong G, Russell MW, Michalek SM. Purification and characterization of a cell-associated glucosyltransferase from Streptococcus sanguis.. J Dent Res. 1997; 76(105).
  • Wu H-Y, Russell MW. Antibodies in murine vaginal tract depend upon local secretory IgA rather than on serum transudation.. AAI. 1997.
  • Russell MW, Wu H-Y, Hajishengallis G, Harokopakis E, Toida N, Hollingshead S, Michalek S. Genetically engineered cellular and molecular mucosal vaccines.. Immunol Cell Biol. 1997; 75(1).
  • Mestecky J, Michalek SM, Moldoveanu Z, Kutteh WH, Crowley-Norwick PA, Morrow C, Russell MW. Targeted mucosal immunizations: antigen delivery systems and compartmentalization of the common mucosal immune system.. Immunol Cell Biol. 1997; 75(1).
  • Wu H-Y, Briles DE, Russell MW. Recombinant cholera toxin B subunit as a nasal mucosal adjuvant.. Immunol Cell Biol. 1997; 75(1).
  • Michalek SM, Hajishengallis G, Harokopakis E, Russell MW, Greenway TE, Katz J, Childers NK. Route/antigen delivery system/adjuvant for inducing salivary immune responses.. Immunol Cell Biol. 1997; 75(1).
  • Harokopakis, E., Hajishengallis, G., Michael Russell, Michalek, S.M.. Oral immunization with avirulent S. typhimurium co-expressing S. mutans adhesin and mucosal adjuvant. J. Dent. Res.. 1997; 76.
  • Childers, N.K., Tong, G., Michael Russell, Michalek, S.M.. Stsreptococcus mutans GS-5 culture supernatant contains glucosyltransferase and a truncated antigen I/II protein. J. Dent. Res.. 1997; 76.
  • Childers, N.K., Mitchell, S.C., Tong, G., Michael Russell, Michalek, S.M.. Purification and characterization of a cell-associated glucosyltransferase from Streptococcus sanguis. J. Dent. Res.. 1997; 76.
  • Russell M, Sibley, DA, Nikolova, EB, Tomana, M, Mestecky, J. IgA antibody as a non-inflammatory regular of immunity.. Immunology. 1996; 89(1).
  • Mestecky J, Michalek SM, Moldoveanu Z, Kutteh WH, Crowley-Nowick PA, Russell MW. Targeted mucosal immunization: compartmentalization of the common mucosal immune system.. 26th Annual Mtg. of the Japanese Society for Immunology. 1996.
  • Russell MW, Wu H-Y, Hajishengallis G, Harokopakis E, Briles DE, Michalek SM, Mestecky J. IgA antibodies for mucosal immune protection.. Period Biol. 1996; 98(1).
  • Russell M. Immunization against mucosal infections: recombinant cholera tox A2/B chimeric protein immunogens.. Mucosal Immunology Update. 1996; 4.
  • Wu, H-Y, Briles, DE, Russell M. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant.. FASEB J. 1996.
  • Zivny, JH, Russell M, Vu, HL, Moldoveanu, Z, Mestecky, J, Elson, CO. Multiple mechanisms of oral tolerance to food antigens in humans.. FASEB J. 1996.
  • Mestecky J, Michalek SM, Moldoveanu Z, Kutteh WH, Crowley-Nowick PA, Russell MW. Targeted mucosal immunization: compartmentalization of the common mucosal immune system.. IABS Task Force on Vaccines. 1996.
  • Mestecky J, Moldoveanu Z, Russell MW, Michalek SM. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.. 2nd International Mtg. on New Approaches to Bacterial Vaccine Development. 1996.
  • Wu, H-Y, Russell M. Induction of mucosal immune responses by intransal immunization using recombinant cholera toxin B subunit (rCTB) as an adjuvant.. ASM. 1996.
  • Hajishengallis, G, Harokopakis, E, Hollingshead, SK, Russell M, Michalek, SM. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin.. ASM. 1996.
  • Wu, H-Y, Nahm, M, Virolainen, A, Russell M, Briles, DE. Protection against nasopharyngeal carriage of pneumococci in mice by mucosal immunization with PspA or a capular type 6B polysaccharide-protein conjugate.. ASM. 1996.
  • Mestecky, J, Russell M. Mucosal immunoglobulins and their contribution to defence mechanisms.. Immunology. 1996; 89(1).
  • Russell MW, Hajishengallis G, Wu H-Y, White PL, Hollingshead SK. Recombinant cholera tox B subunit-protein chimeric immunogens for mucosal vaccines.. Clin Immunol Immunopathol. 1995; 76.
  • Wu H-Y, Nikolova EB, Russell MW. Ig isotypes, cytokine profiles, and memory in nasal and gut-associated lymphoid tissues after mucosal immunization.. Clin Immunol Immunopathol. 1995; 76.
  • Russell M, Moldoveanu, Z, White, P, Lallone, RL, Mestecky, J, Sibert, G, Michalek, SM. Mucosal immunization of rhesus monkeys with a bacterial protein antigen coupled to cholera toxin B subunit.. ASM. 1995.
  • Wu H-Y, Nikolova EB, Russell MW. Immune memory and dominance of type 2 T cell cytokines in nasal-associated lymphoid tissue (NALT) of mice.. FASEB J. 1995; 9.
  • Hajishengallis G, Hollingshead SK, Koga T, Russell MW. Oral Immunization with Streptococcus mutans AgI/II genetically coupled to cholera toxin A2B subunits.. J Dent Res. 1995; 74.
  • Phipps LS, Nikolova EB, Russell MW. Comparison of IL-8 and GM-CSF on neutrophil phagocytosis of IgA-oponized particles.. J Dent Res. 1995; 74.
  • Russell MW, Nikolova EB, Phipps LS, White PL, Hajishengallis G, Metecky J, Kilian M. IgA a Heterogeneous Immunoglobulin with Versatile Functions.. J Cell Biochem. 1995; 19A.
  • Hollingshead SK, Hajishengallis G, Koga T, White P, Wu H-Y, Michalek SM, Russell MW. Novel mucosal immunogen genetically constructed from a protein antigen and cholera toxin A2 and B segments.. J Cell Biochem. 1995; 19A.
  • Mestecky J, Moldoveanu Z, Russell MW, Novak M, Wu H-Y, Hajishengallis G, Menge AC, Michalek SM. Roles of inductive sites in region-specific secretory immune responses of diverse mucosal tissues.. J Cell Biochem. 1995; 19A.
  • Hajishengallis, G, Koga, T, Hollingshead, SK, Russell M. Construction of a mucosal immunogen by gene fusion of protein antigen and cholera toxin segments.. ASM. 1994.
  • Wu, H-Y, Russell M. Characterization of nasal-associated lymphoid tissue (NALT) in mice.. FASEB J. 1994; 8.
  • Hajishengallis G, Koga T, Russell MW. Identification of functional domains of Streptococcus mutans AgI/IIa.. J Dent Res. 1994; 73.
  • Russell MW, Nikolova EB. Non-inflammatory and pro-inflammatory interactions of human IgA with neutrophils.. J Dent Res. 1994; 73.
  • Nikolova, EB, Russell M. Dual effect of IgA antibodies on the respiratory burst of neutrophils.. FASEB J. 1994; 8.
  • Nikolova E, Tomana M, Mestecky J, Russell MW. Human secretory IgA antibodies inhibit alternative pathway complement activation.. J Immunol. 1993; 150.
  • Wu H-Y, Nikolova E, Beagley KW, Eldridge JH, Russell MW. Comparison of T cell responses in associated lymphoid tissues of mice immunized intranasally (i.n.) or intragastrically (i.g.).. J Immunol. 1993; 150.
  • Russell MW, Wu H-Y, White P, Nikolova E, Hajishengallis G, Katz J, Michalek S. Intranasal immunization and mucosal protection by adherence-inhibiting S-IgA antibodies.. 24th Annual Meeting, Scandinavian Society for Immunology. 1993.
  • Russell MW, Wu H-Y, White PL, Katz J, Michalek SM. Salivary immunity to caries induced by mucosal immunization with S. mutans protein Ag I/II.. J Dent Res. 1993; 72.
  • Hajishengallis G, Russell MW. Streptococcus mutans cell surface determinants involved in adherence to saliva-coated hydroxyapatite.. J Dent Res. 1993; 72.
  • Wu, H-Y, White, P, Russell M. Distribution of antibody-secreting cells and antibodies in secretions of mice mucosally immunized with S. mutans.. FASEB J. 1992; 6.
  • Childers NK, Zhang S, Miller E, Russell MW, Michalek SM. Streptococcus mutans (Sm) carbohydrate/protein conjugates for immunization studies.. J Dent Res. 1992; 71.
  • Hajishengallis G, Russell MW. Inhibition of Streptococcus mutans Ag I/II binding to saliva-coated hydroxylapatite by S-IgA antibodies.. J Dent Res. 1992; 71.
  • Hajishengallis, G., Nikolova, E., Michael Russell. Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) anatibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage. Infect. Immun.. 1992; 60.
  • Russell MW, Wu H-Y, White PL, Hajishengallis G, Michalek SM, Katz J, Harmon C, Moldoveanu Z. Introduction and functional activity of bacterial adherence-inhibiting secretory IgA antibodies at mucosal surfaces.. ASCB/EMBO Summer Conference. 1991.
  • Russell M, Wu, H, White, P. Differential distribution of specific mucosal antibody responses after peroral immunization with protein-CTB conjugates.. FASEB J. 1991; 5.
  • Wu, H-Y, Beagley, KW, Eldridge, JH, Mestecky, J, Russell M. Phenotypic distribution and cytokine production of T lymphocytes in the mouse liver.. FASEB J. 1991; 5.
  • Russell MW, Reinholdt J, Killian M. A mechanism whereby IgA1 proteases may promote invasive infections by mucosal pathogens.. Symposium on Microbial Adhesion and Invasion. 1990.
  • Russell MW, Wu H, White P, Mestecky J. Oral immunization with protein-CTB conjugates for the induction and mucosal and circulating antibodies.. 10th Mtg., European Federation of Immunological Societies. 1990.
  • Russell M, White, PL. Human IgA antibodies, or Faba fragments, inhibit IgG antibody-mediate complement fixation by inhibiting Clq binding and subsequent steps.. FASEB J. 1990; 4.
  • Wu, H, Russell M, Mestecky, J. Antibody-secreting cells in the liver after parenteral or oral immunization in mice.. FASEB J. 1990; 4.
  • Wu, H, Russell M. Lack of immunological cross-reactivity between surface protein antigen I/II of Streptococcus mutans and human heart.. FASEB J. 1990; 4.
  • Russell MW, Mansa B, Reinholdt J, Kilian M. Anti-inflammatory properties of human IgA antibodies in competition with complement-fixing IgG antibodies.. 7th International Congress of Immunology. 1989.
  • Russell M, Reinholdt, J, Mansa, B, Kilian, M. Anti-inflammatory properties of human IgA antibodies and their Fab fragments.. FASEB J. 1989; 3.
  • Mestecky J, Brown TA, Russell MW, Tarkowski A, Lue C, Moldoveanu Z, Michalek S, Radl J, Haaijman JJ, McGhee JR. Naturally occurring or artificially induced IgA1 and IgA2 antibodies to microbial antigens in human sera and external secretions.. 9th European Immunology Meeting. 1988.
  • Mullins AL, Bhugra B, Russell MW. Analysis of epitopes in Streptococcus mutans surface protein antigens.. 87th Annual Meeting, ASM. 1987.
  • Mullins AL, Bhugra B, Russell MW. Western blot analysis of Streptococcus mutans protein antigen I/II and its subcomponents.. 72nd Annual Meeting, Southeastern Branch ASM. 1986.
  • Pfanenstiel YT, Moldoveanu Z, Czerkinsky C, Russell MW. Specific and non-specific immune responses in mice immunized with Streptococcus mutans.. 72nd Annual Meeting, Southeastern Branch ASM. 1986.
  • Russell M, Czerkinsky, C, Moldoveanu, Z. Investigation of cross-reactivity between heart tissue and Streptococcus mutans.. 6th International Congress of Immunology. 1986.
  • Russell MW, Czerkinsky CC, Moldoveanu Z, Mestecky J. Enumeration of antibody-secreting cells in mice immunized with Streptococcus mutans.. Fed Proc. 1985; 44.
  • Russell MW, Mansson-Rahemtulla B, Rahemtulla F. Binding of Streptococcus mutans and its surface protein antigens to components of saliva.. J Dent Res. 1985; 64.
  • Russell MW. Streptococcus mutans adhesins and salivary proteins.. J Dent Res. 1985; 64.
  • Galla, JH, Russell M, Hammond, D, Spotswood, M, Mestecky, J. Environmental antigens (E Ag) in IgA nephropathy (IgA N).. American Society for Clinical Investigation. 1985.
  • Galla, JH, Russell M, Hammond, D, Spotswood, M, Mestecky, J. Environmental antigens (E Ag) in IgA nephropathy (IgAN). American Society of Nephrology. 1984.
  • Russell M. Interaction of Streptococcus mutans in surface proteins with salivary components.. International Workshop on Molecular Interactions in Oral Microbial Adherence and Aggregation. 1984.
  • Russell MW. Protein antigens of Streptococcus mutans and immunity to dental caries.. J Dent Res. 1984; 63.
  • Filler SJ, Gregory RL, Michalek SM, Mestecky J, Russell MW, Kentros GA, McGhee JR. Salivary antibodies to Streptococcus mutans in caries-free and -active individuals.. J Dent Res. 1984; 63.
  • Gregory RL, Filler SJ, Michalek SM, Mestecky J, Russell MW, McGhee JR. Human salivary IgA antibodies prevent Streptococcus mutans colonization.. J Dent Res. 1984; 63.
  • Russell MW, Hammond D, Galla J, Mestecky J. Serum IgA antibodies to environmental antigens in patients with IgA nephropathy.. Fed Proc. 1984; 43.
  • Russell M, Brown, TA, Phillips, JO, Mestecky, J. The differential control of environmental antigens by serum and secretory IgA.. Fifth International Congress of Immunology. 1983.
  • Russell MW, Brown TA, Kulhavy R, Mestecky J. Reduced IgA mediated hepatobiliary transport of anatigen in NZB mice.. Fed Proc. 1983; 42.
  • Brown TA, Russell MW, Mestecky J. Elimination of intestinally absorbed antigen into the bile IgA.. Fed Proc. 1983; 42.
  • Moro I, Russell MW. Ultrastructural localization of protein surface antigens of Streptococcus mutans.. J Dent Res. 1983; 62.
  • Brown TA, Russell MW, Mestecky J. Involvement of the liver in the removal of immune complexes of various immunoglobulin isotypes.. 9th International Congress, Reticuloendothelial Society.. 1982.
  • Russell MW, Holt RG. Comparison of protein surface antigens from Streptococcus mutans serotype c and g.. J Dent Res. 1982; 61(249).
  • Brown TA, Russell MW, Mestecky J. IgA and immune complex transport into saliva and other secretions.. J Dent Res. 1982; 308(1170).
  • Russell MW, Brown TA, Kulhavy RM, Mestecky J. IgA-mediated excretion of bacterial polysaccharide by hepatobiliary transport.. Fed Proc. 1982; 41(291).
  • Brown TA, Russell MW, Kulhavy RM, Mestecky J. IgA-mediated elimination of antigens by the hepatobiliary route.. Fed Proc. 1982; 41(960).
  • Kiyono H, Russell MW, Mosteller LM, Prince SJ, Wannemuehler MJ, Brown TA, Kulhavy R, Mesteck J, McGhee JR. Natural immune responses to milk proteins in humans.. Fed Proc. 1982; 41.
  • Phillips JO, Russell MW, Brown TA, Mestecky J. Hepatobiliary transport of human immunoglobulins from serum into bile of mice.. Fed Proc. 1982; 41.
  • Lehner T, Russell MW, Caldwell J, Lamb JR. Immunization with a purified protein from Streptococcus mutans and immunoregulation of B cell antibodies by T cell helper activity.. J Dent Res. 1981; 60 (S(B1085).
  • Smith R, Lehner T, Russell MW, Caldwell J. The relationship between specific antibodies to streptococcal antigens I, II, and III, and protection against dental caries.. J Dent Res. 1981; 60 (S(B1141).
  • Russell MW, Brown TA, Mestecky J. Serum IgA mediates hepato-biliary excretion of antigen.. Fed Proc. 1981; 40(1100).
  • Brown TA, Russell MW, Mestecky J. Mechanisms of hepatic transport of IgA immune complexes from the circulation into the bile.. Fed Proc. 1981; 40(1101).
  • Russell MW, Brown TA, Mestecky J. Serum IgA mediates hepatobiliary excretion of antigen.. British Society of Immunology. 1981.
  • Russell MW. Purification and properties of a protein antigen of Streptococcus mutans.. J Dent Res. 1980; 59 (S(D1803).
  • Russell MW, Bergmeier LA, Zander ED. Protein surface antigens of Streptococcus mutans.. American Society for Microbiology (ASM), 80th Annual Meeting.. 1980.
  • Lehner T, Russell MW, Challacombe SJ, Scully CM, Caldwell J. The functions of IgG, IgA, and IgM antibodies to Streptococcus mutans in active and passive immunization of monkeys.. J Dent Res. 1979; 58 (S(C1234).
  • Scully CM, Russell MW, Lehner T. Phagocytosis of Streptococcus mutans in relation to protection against dental caries.. J Dent Res. 1979; 58 (S(1234).
  • Russell MW, Challacombe SJ. Transfer of immunoglobulin from plasma to the mouth in rhesus monkeys.. J Dent Res. 1979; 58 (S(C1235).
  • Russell MW, Challacombe SJ, Bergmeier LA, Hawkes JE. Transfer of immunoglobulins from plasma to the mouth in rhesus monkeys.. British Society of Immunology. 1978.
  • Challacombe, S.J., Michael Russell. Estimation of the intravascular half-lives of normal rhesus monkey IgG, IgA, and IgM.. British Society for Immunology.. 1978.
  • Russell MW, Challacombe SJ, Lehner T. Antibodies to defined antigens of Streptococcus mutans in immunity to caries.. J Dent Res. 1977; 56 (S(D121).
  • Lehner T, Russell MW, Challacombe SJ, Caldwell J, Wilton JMA. Passive transfer of antibodies and cellular immunity in protection against dental caries.. J Dent Res. 1977; 56 (S(D121).
  • Russell MW, Bergmeier LA. Separation, purification, and estimation of rhesus monkey serum immunoglobulins; cross-reactivity with human immunoglobulins.. British Society for Immunology. 1977.
  • Russell MW. Separation of antigens of Streptococcus mutans and their significance in immunization against dental caries.. J Dent Res. 1976; 55 (S(D122).
  • Russell MW, Challacombe SJ, Lehner T. Inhibition of glucosyltransferase by sera from rhesus monkeys immunized with Streptococcus mutans.. J Dent Res. 1975; 54 Sp(L100).
  • Russell MW, Reiter B. Factors affecting the phagocytosis of Staphyloccus aureus by bovine polymorphonuclear leukocytes in milk.. J Gen Microbiol. 1972; 71(iv).
See All (184 Total) >
Books and Book Chapters:
  • Fujihashi K Russell MW Hajishengallis G. Immunological intervention against oral diseases. 2014.
  • Hajishengallis G Russell MW. Innate humoral defense factors. 2013.
  • Russell MW Kilian M Mantis NJ Corthésy B. Biological activities of mucosal immunoglobulins. 2013.
  • Russell MW. Microbial evasion of IgA functions. 2013.
  • Russell MW Whittum-Hudson J Fidel P Hook EW III Mestecky J. Immunity to sexually transmitted infections. 2013.
  • Mestecky J Cheroutre H Kelsall B Lambrecht B Russell MW Strober W. Mucosal Immunology, 4th Edition. 2013.
  • Kaetzel CS Russell MW. Phylogeny and comparative physiology of IgA. 2013.
  • Mestecky J Russell MW. Overview: mucosal vaccines. 2013.
  • Mestecky J Russell MW. Overview: immunology and immunopathology of the genitourinary tract. 2013.
  • Russell MW Lambrecht B. Overview: oral cavity, upper airways, and head and neck. 2013.
  • Russell MW, Hook EW. Gonorrhea.. 2009.
  • Russell MW, Hook EW III. Gonorrhea. Vaccines for Biodefense and Emerging and Neglected Diseases. 2009; 49.
  • Hajishengallis G, Russell MW. Molecular approaches to vaccination against oral infections.. Molecular Oral Microbiology. 2008(11).
  • Russell MW. Biological functions of IgA.. Mucosal Immune Defense: Immunoglobulin A.. 2007(6).
  • Russell M, Bobek, LA, Brock, JH, Hajishengallis, G, Tenovuo, J. Innate humoral defense factors.. Mucosal Immunology, 3rd Ed.. 2005(5).
  • Peppard JV, Kaetzel CS, Russell MW. Phylogeny and comparative physiology of IgA.. Mucosal Immunology, 3rd Edition.. 2005(11).
  • Russell MW, Kilian M. Biological activities of IgA.. Mucosal Immunology, 3rd Ed.. 2005(14).
  • Killian M, Russell MW. Microbial evasion of IgA functions.. Mucosal Immunology, 3rd Edition.. 2005(15).
  • Russell MW, Sparling PF, Morrison RP, Cauci S, Fidel PL, Martin D, Hook EW, Mestecky J. Mucosal immunology of sexually transmitted diseases.. Mucosal Immunology, 3rd Ed.. 2005(99).
  • Russell MW, Bobek LA, Brock JH, Hajishengallis G, Tenovuo J. Innate humoral defense factors. Mucosal Immunology, 3rd Edition. 2005.
  • Vu HL, Troubetzkoy S, Nguyen VQ, Russell MW, Mestecky J. Absolute quantification of specific nucleic acids by RT-PCR using a nonlinear mathematical model for data analysis.. PCR Technology: Current Innovations, 2nd Edition.. 2004(23).
  • Mestecky J, Russell MW. Intestinal IgA: Role in host defense.. Microbial Pathogens and the Intestinal Epithelial Cell.. 2003(6).
  • J. Mestecky, Russell M. Intestinal IgA: Role in host defense. Microbial Pathogens and the Intestinal Epithelial Cell. 2003.
  • Mestecky, J., Michael Russell. Mucosal antibodies and induction of the immunoglobin A response. Food Allergy and Intolerance, 2nd edn.. 2002.
  • Mestecky J, Russell MW. Mucosal antibodies and induction of the IgA response.. Food Allergy and Intolerance, 2nd Ed.. 2002(10).
  • Mestecky J, Russell MW. Intestinal IgA: Role in host defense.. Microbial Pathogens and the Intestinal Epithelial Cell. 2002.
  • Pruitt KM, Rahemtulla F, Rahemtulla B, Russell MW. Innate humoral factors. Mucosal Immunology, 2nd Ed.. 1999(5).
  • Peppard JV, Russell MW. Phylogenetic development and comparative physiology of IgA.. Mucosal Immunology, 2nd Ed.. 1999(11).
  • Russell MW, Kilian M, Lamm ME. Biological activities of IgA.. Mucosal Immunology, 2nd Ed.. 1999(14).
  • Killian M, Russell MW. Bacterial evasion of mucosal immune defenses.. Mucosal Immunology, 2nd Ed.. 1999(15).
  • Hook EW, Pate M, Hedges SR, Russell MW, Mestecky J. Mucosal immunology of sexually transmitted disease.. Mucosal Immunology, 2nd Ed.. 1999(93).
  • Hook, E.W., Pate, M., Hedges, S.R., Michael Russell, Mestecky, J.. Mucosal immunology of sexually transmitted diseases. Mucosal Immunology, 2nd Edn.. 1999.
  • Kilian, M., Michael Russell. Bacterial evasion of mucosal immune defenses.. Mucosal Immunology, 2nd Edn.. 1999.
  • Michael Russell, Kilian, M., Lamm, M.E.. Biological activities of IgA. Mucosal Immunology, 2nd Edn.. 1999.
  • Peppard, J.V., Michael Russell. Phylogenetic development and comparative physiology of IgA. Mucosal Immunology, 2nd Edn.. 1999.
  • Pruitt, K.M., Rahemtullal, F., Rahemtulla, B., Michael Russell. Innate humoral factors. Mucosal Immunology, 2nd edn.. 1999.
  • Michael Russell. Future strategies to control oral infections. Oral Biology at the Turn of the Century: Misconceptions, Truths, Challenges and Prospects. 1998.
  • Hedges, S.R., Michael Russell, Mestecky, J.. Diagnostic significance of antibodies in oral secretions. Rapid Detection of Infectious Agents. 1998.
  • Pate, M.S., Hook, E.W., Hedges, S.R., Sibley,D.A., Michael Russell, Mestecky, J.. Chlamydia infected male urethra cytokine detection and profile. Chlamydial Infections. 1998.
  • Metecky, J., Michalek, S.M., Moldoveanu, Z., Kutteh, W.H., Crowley-Nowick, P.A., Murrow, C., Michael Russell. Targeted mucosal immunizations: antigen delivery systems and compartmentalization of the common mucosal immune system. Mucosal Solutions: Advances in Mucosal Immunology. 1997; 2.
  • Michael Russell, Wu, H.-Y., Hajishengallis, G., Harokopakis, E., Toida, N., Hollingshead, S.K., Michalek, S.M.. Genetically engineered cellular and molecular mucosal vaccines: chimeric immunogens based on cholera toxin and their delivery in a Salmonella vector. Mucosal Solutions: Advances in Mucosal Immunology. 1997; 2.
  • Michael Russell, Hajishengallis, G., Wu, H.-Y., Hollingshead, S.K., Briles, D.E., Moldoveanu, Z., Michalek, S.M., Mestecky, J.. Recombinant CTB-linked immunogens for inducing antibodies in secretions. Pathogenic Neisseria. 1996.
  • Michael Russell. Mucosal immunication with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. mucosal Immunication: Genetic Approaches and Adjuvants. 1996.
  • Michalek, S.M., Georgios Hajishengallis, Redman, T.K., Harokopakis, E., Michael Russell. Mucosal antigen delivery systems/adjuvants for inducing protective immunity against mutans streptococci.. In: Germfree Life and its Ramifications, Hashimoto K. et al. (eds.). 1996.
  • Hedges, S.R., Blalock, C., Kallman, L., Mayo, M.S., Smith, K., Mestecky, J., Hook, E., Michael Russell. Infection with Neisseria gonorrhoeae induces acute systemic, but not locall, immune and inflammatory responses: effects of concomitant infection with trichomonas vaginalis and Chlamydia trachomatis. Pathogenic Neisseria. 1996.
  • Mestecky, J., Michael Russell. J. Chain. Human Protein Data. 1995.
  • Mestecky, J., Michael Russell, Jackson, S., Michalek, S.M., Tlaskalova, H., Sterzl, J.. Advances in Mucosal Immunology. Advances in Experimental Medicine and Biology. 1995; 371.
  • Kilian, M., Michael Russell. Function of mucosal immunoglobulins. Handbook of Mucosal Immunology. 1994.
  • Mestecky, J., Michael Russell. Immunoglobulin A.. Human Protein Data. 1992.
  • Michalek, S.M., Childers, N.K., Katz, J., Dertzbaugh, M., Zhang, S., Michael Russell, Macrina, F.L., Jackson, S., Mestecky, J.. Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses. Genetically Engineered Vaccines. 1992; 327.
  • Michael Russell, Wu, H.-Y., White, P.L., Takahashi, I., Okahashi, N., Koga, T.. Peroral immunization with a cholera toxin-linked bacterial protein antigen and synthetic peptide. Genetically engineered Vaccines. 1992; 327.
  • Moldoveanu, Z., Czerkinsky, C.C., Michalek, S.M., Michael Russell, Adler, R., Mestecky, J.. The use of ELISPOT to evaluate the immune response at the single cell level following immunization with S. mutans. Frontier of Mucosal Immunology. 1991; 1.
  • Michalek, S.M., Katz, J., Childers, N.K., Moldoveanu, Z., Michael Russell, Jackson, S., Dertzbaugh, M., Mestecky, J.. Characteristics of oral Streptococcus mutans vaccines important for the induction of mucosal immune responses in rats. Frontiers of Mucosal Immunology. 1991.
  • Michael Russell, Wu, H., White, P., Czerkinsky, C., Holmgren, J.. Oral immunization with Streptococcus mutans antigen I/II conjugated to cholera toxin B subunit. Frontiers of Mucosal Immunology. 1991; 1.
  • Michael Russell, White, P., Reinholdt, J., Kilian, M.. IgA, complement, and a role for bacterial IgA1 protease in mucosal infections. Frontiers of Mucosal Immunology. 1991; 1.
  • Quiding, M., Nordstrom, I., Larsson, L., Andersson, G., Michael Russell, Jonsson, R., Svennerholm, A.-M., Hanson, L.A., Kilander, A., Granstrom, G., Friman, W., Holmgren, J., Czerkinsky, C.. The cellular basis of intestinal immunity in humans. Frontiers of Mucosal Immunology. 1991; 1.
  • Mestecky, J., Waldo, F.B., Britt, W.J., Julian, B.A., Tomana, M., van den Wall Bake, A.W.L., Michael Russell, Galla, J.H., Moldoveanu, Z., Jackson, S.. Exogenous antigens deposited in the glomeruli of patients with IgA nephropathy. Pathogenesis of IgA Nephropathy. 1990.
  • Mestecky, J., Lue, C., Tarkowski, A., Moldoveanu, Z., Czerkinsky, C., Ladjeva, I., Peterman, J.H., Michael Russell, Kiyono, H., McGhee, J.R.. Induction of human secretory and serum immune responses; molecular properties of IgA antibodies. Advances in Mucosal Immunology. 1990.
  • Michael Russell, Mansa, B., Reinholdt, J., Kilian, M.. Inhibition of complement activation by human IgA antibodies and their Fab fragments. Advances in Mucosal Immunology. 1990.
  • Mestecky, J., Moldoveanu, Z., Komiyama, K., Tomana, M., Phillips, J.O., Michael Russell, Brown, T.A., Crago, S.S., Moro, I.. Interaction of IgA with non-lymphoid cells. Mucosal Immunity and Infection at Mucosal Surfaces. 1988.
  • Mestecky, J., Czerkinsky, C., Brown, T.A., Michalek, S.M., Michael Russell, Jackson, S., Scholler, M., McGhee, J.R.. Human immune responses to Streptococcus mutans. Molecular Microbiology and Immunobiology of Streptococcus mutans. 1986.
  • Michael Russell, Brown, T.A., Phillips, J.O.. Contribution of hepatobiliary transport of IgA to disposal of bacterial antigenic products. Bacteria and the Host: Proceedings of the International Symposium. 1986.
  • Michael Russell. Protein antigens of Streptococcus mutans. Molecular Microbiology and Immunobiology of Streptococcus mutans. 1986.
  • Mestecky, J., Michael Russell, Jackson, W., Julian, B.A., Galla, J.H.. Immunological studies on IgA-associated renal diseases. Mucosal Immunity. IgA and Polymorphononuclear Neutrophils. 1985.
  • Mestecky, J., Kutteh, W., Crago, S.S., Laven, G.T., Brown, T.A., Michael Russell, Moldoveanu, Z.. Cellular and humoral pathways in the IgA mucosal system. Recent Advances in Mucosal Immunity. 1982.
  • Lehner, T., Michael Russell, Scully, C.M., Challacombe, S.J., Caldwell, J.. The role of the IgG, IgM and IgA classes of antibodies to Streptococcus mutans in protection againsts caries in rhesus monkeys. Pathogenic Streptococci. 1979.
  • Michael Russell, Caldwell, J., Lehner, T.. Antibody response to Streptococcus mutans antigens during immunization against dental caries. Pathogenic Streptococci. 1979.
See All (67 Total) >
Professional Memberships:
  • American Association for Reproductive Immunology Professional Society Membership. (2007)
  • American Association for the Advancement of Science Professional Society Membership. (2004)
  • Alps-Adria Society for Immunology of Reproduction Professional Society Membership - by invitation only. (1997-2007)
  • Society for Mucosal Immunology Professional Society Membership. (1987)
  • American Association of Immunologists Professional Society Membership. (1982)
  • American Society for Microbiology Professional Society Membership. (1980)
  • American Association for Dental Research (1979)
  • British Society for Immunology Professional Society Membership. (1976)
  • International Association for Dental Research Professional Society Membership. (1976)
Presentations:
  • The Th17 Axis of Immunity: A New Dimension in Comprehending the Host Response to Neisseria gonorrhoeae, International Pathogenic Neisseria Conference, International Pathogenic Neisseria (2008)
  • Workshop on Immune Defense Mechanisms at the Mucosal Surface, Workshop on Immune Defense Mechanisms at the Mucosal Surface, National Institute of Allergy and Infectious Diseases (2008)
  • Bridging Innate and Adaptive Immunity to Infections in the Genital Tract, 10th Annual Upstate New York Immunology Conference, 10th Annual Upstate New York Immunology (2007)
  • Immunoglobulins and Antibody Responses within Genital Secretions Reveal the Immunological Uniqueness of the Genital Mucosae, American Society for Reproductive Immunology, 27th Annual Meeting, American Society for Reproductive Immunology (2007)
  • Novel Mechanisms of Immunomodulatory Activity by Type I and Type II Enterotoxins, European Mucosal Immunology Group 5th Meeting, European Mucosal Immunology Group (2006)
  • Streptococcus mutans AgI/II - Caries Vaccine Antigen, Adhesin, and Immunomodulator, International Association for Dental Research, 84th General Session, International Association for Dental Research, (2006)
  • Entertoxin Adjuvants: Novel Modes of Action Revealed by Type II Toxins, Roswell Park Cancer Institute (2006)
  • Enterotoxin Adjuvants: Novel Modes of Action Revealed by Type II Toxins, University of Florida at Gainesville (2005)
  • Immunomodulation by Enterotoxin-Based Adjuvants and Vaccine Delivery Systems, 7th Annual Upstate New York Immunology Conference (2004)
  • Mucosal Immunity in the Genital Tract: Challenges and Prospects for Combatting Infection, International Organization for Mycoplasmology, 15th Congress (2004)
  • Bacterial Enterotoxins and the Modularion of Mucosal Immune Responses, Naval Medical Research Center/Walter Reed Army Institute of Research (2004)
  • Bacterial Enterotoxins and the Modulation of Mucosal Immune Responses, The Forsyth Institute (2003)
  • A Caries Vaccine, European Organization for Caries Research (ORCA), 50th Anniversary Congress, European Organization for Caries Research (ORCA) (2003)
  • Mucosal Immunization Strategies for the Control of Oral Infections, Symposium "Immune Mechanisms in the Oral Cavity-Relevance to Health and Disease", International Association for Dental Research (2003)
  • Bacterial Enterotoxins and the Modulation of Mucosal Immune Responses, Albany Medical College (2003)
  • Workshop on Vaccination Against Dental Caries, Workshop on Vaccination Against Dental Caries, National Institute of Dental and Craniofacial Research (2003)
  • Bacterial Entertoxins and the Modulation of Mucosal Immune Responses, University of Oslo, Norway (2002)
  • The failure of protective immunity against genital infection with Neisseria gonorrhoeae is twofold, 13th International Pathogenic Neisseria Conference (2002)
  • Becterial enterotoxins and the modulation of mucosal immune responses, University of Oslo (2002)
  • Bacterial eneterotoxins and the modulation of mucosal immune responses, University of Bergen (2002)
  • Bacterial Enterotoxins and the Modulation of Mucosal Immune Responses, University of Bergen, Norway (2002)
  • Studies on the lack of protective immunity against genital infection witih Neisseria gonorrhoeae, 11th International Congress of Mucosal Immunology (2002)
  • Analysis of genital immune responses in males with gonococcal urethritis, 11th International Congress of Mucosal Immunology (2002)
  • Downregulation of the p65 subunit of the p65 subunit of NF-kappa B induces monocytic cell hyporesponsiveness to secondary stimulation with P. gingivalis FimA, ASM (2002)
  • How "common" is the common mucosal immune system and its individual compartments? Implications for vaccine development, New Approaches to Bacterial Vaccine Development (2002)
  • Bacterial Enterotoxins: Multiple Effects in the Modulation of Mucosal Immune Responses, Case-Western Reserve University (2002)
  • Bacterial enterotoxins: multiple effects in the modulation of mucosal immune responses, Case-Western Reserve University (2002)
  • Adjuvants and Chimeras: Cellular and Molecular Mechanisms of Immunomodulation, 102nd General Meeting, ASM, ASM (2002)
  • Adjuvants and chimeras: cellular and molecular mechanisms of immunomodulation, 102nd General Meeting, ASM, symposium on Bacterial Enterotoxins as Mucosal Immunomodulators (2002)
  • Immuniation for the protection of the reproductive tract, VIIIth International Congress on Reproductive Immunology (2001)
  • Effector mechanisms of IgA, 11th International Congress of Immunology, symposium on Effector Mechanisms at Mucosal Tissues (2001)
  • Immunization for the Protection of the Reproductive Tract, VIII International Congress on Reproductive Immunology (2001)
  • Effector Mechanisms of IgA, 11th International Congress of Immunology (2001)
  • IgA, a two-edged sword, in the control of oral infections, National Institute of Dental and Craniofacial Research (2001)
  • IgA, A Two-Edged Sword, In the Control of Oral Infections, National Institute of Dental and Craniofacial Research, NIDCR (2001)
  • Proinflammatory cytokine induction by bacterial protein adhesins via activation of the CD14-TLR2/4, AAI (2001)
  • The paucity of mucosal immune responses in human gonorrhea favors vaccine development, Twelfth International Pathogenic Neisseria Conference (2000)
  • Mucosal immune system of the human genital tract, 3rd Congress of the European Society for Reproductive and Developmental Immunology (2000)
  • Potential for Vaccines in the Prevention of Carious Lesions, International Conference on Alternatives to the Management of Carious Lesions, International Conference (2000)
  • Potential for vaccines in the prevention of carious lesions, International conference on Alternatives to the Management of Carious Lesions (2000)
  • Development of a vaccine against dental caries, 10th Pan-Cretan Stomatologic Congress (2000)
  • Generation of genital immune responses by infection or vaccination, Czech Society for Reproductive Immunology (2000)
  • Altered accessory cell function in PBMC from adult periodontitis patients, ASM (2000)
  • A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis, AAI (2000)
  • Prevention of dental caries by intervention in the colonization of tooth surfaces by Streptococcus mutans, 10th Pan-Cretan Stomatologic Congress (2000)
  • Generation of Genital Immune Responses by Infection or Vaccination, Czech Society for Reproductive Immunology (2000)
  • Generation of genital immune responses by infection or vaccination, Czech Society for Reproductive Immunology (2000)
  • Inhibition of Streptococcus mutans glucosyltransferase by a nonimmunoglobulin factor in human saliva, IADR (2000)
  • Immunostimulatory activity of CT- and LT-IIa-based chimeric proteins, IADR (2000)
  • Strategies of Immunization Against Mucosal Infections, Merieux Foundation International Symposium "Otitis Media: A Preventable Disease?", Merieux Foundation (2000)
  • Strategies of immunization against mucosal infections, Merieux Foundation International Symposium "Otitis Media: a Preventable Disease?" (2000)
  • Immunization routes for compartmentalized mucosal immune responses, Keystone Symposium on "Innate and acquired immunity at mucosal surfaces" (2000)
  • Immunity where it matters: the mucosal frontier, Mississippi State University (1999)
  • Immunity Where It Matters: The Mucosal Frontier, Mississippi State University (1999)
  • Immunity Where It Matters: The Mucosal Frontier, State University of New York at Buffalo, Department of Microbiology/Center for Microbial Pathogenesis (1999)
  • Immunity where it matters: the mucosal frontier, University at Buffalo (1999)
  • Mucosal immune responses in human gonorrhea, 10th International Congress of mucosal Immunology (1999)
  • Unique phenotype and function distinguish mucosal machrophages from blood monocytes, 10th International Congress of Mucosal Immunology (1999)
  • Mucosal vaccines based on cholera toxin B subunit, 10th International Congress of Mucosal Immunology (1999)
  • Modification of macrophage and neutrophil responses to bacteria by IgA antibodies, 10th International Congress of Mucosal Immunology (1999)
  • Cytokine and immunoglubulin responses in serum and urethral secretions of Chlamydia trachomatis-infected men, 10th International Congress of Mucosal Immunology (1999)
  • Role of glycans in effector functions of IgA in health and disease, 10th International Congress of Mucosal Immunology (1999)
  • Induction of mucosal immune responses in the human genital tract, 3rd International Meeting, New Approaches to Bacterial Vaccine Development (1999)
  • Importance of the lilnk between cholera toxin (CT) A1 and A2 subunits for the stability of chimeric SBR-CTA2/B mucosal immunogens, ASM (1999)
  • Porphyromonas gingivalis-specific serum antibodies from adult periodonitis patients, ASM (1999)
  • Immunological Defense in Saliva, 5th European Symposium "Application of Saliva in Clinical Practice and Research", 5th European Symposium (1999)
  • Construction and characterization of a GTF glucan-binding domain-thoredoxin chimeric protein, IADR (1999)
  • Immunity where it matters: the mucosal frontier, Medical College of Ohio (1999)
  • Immunity Where It Matters: The Mucosal Frontier, Medical College of Ohio (1999)
  • New Strategies and Applications of Mucosal Immunization Using Recombinant CTA2/B Chimeric Immunogens, Wayne State University (1998)
  • New strategies and applications of mucosal immunization using recombinant CTA2/B chimeric immunogens, Wayne State University (1998)
  • Functional aspects of IgA and novel approaches to mucosal vaccination, University of Vienna (1998)
  • Mucosal immune response: a novel approach to immunization, Masaryk University (1998)
  • IgA antibodies and mucosal immune protection, Prague Dental Institute (1998)
  • Mucosal immunity in the genital tract: prospects for vaccines against STDs, Fourth International Meeting "Mechanisms in Local Immunity" (1998)
  • Induction of mucosal immune responses in the human genital tract: relevance to the development of vaccines against human immunodeficiency virus (HIV), Fourth International Meeting "Mechanisms in Local Immunity" (1998)
  • Functional Aspects of IgA and Novel Approaches to Mucosal Vaccination, University of Vienna, Austria (1998)
  • Mucosal Immune Response: A Novel Approach to Immunization, Masaryk University, Brno, Czech Republic (1998)
  • IgA Antibodies and Mucosal Immune Protection, Prague Dental Institute, Czech Republic (1998)
  • Mucosal Immunity in the Genital Tract: Prospects for Vaccines Against STDs, Fourth International Meeting "Mechanisms in Local Immunity" (1998)
  • Mucosal immunity in the genital tract: prospects for vaccines against STDs, Fourth International Meeting "Mechanisms in Local Immunity" (1998)
  • Immunological Defense in Saliva, 5th European Symposium "Application of Saliva in Clinical Practice and Research (1998)
  • Future strategies to control oral infections, European Research Group for Oral Biology, 30th anniversary conference (1998)
  • Future Strategies to Control Oral Infections, European Research Group for Oral Biology, 30th Anniversary Conference, European Research Group for Oral Biology (1998)
  • IgA as an Anti-Inflammatory Regulator of Immunity, International Association for Dental Research, 76th General Session (1998)
  • IgA as an anti-inflammatory regulator of immunity, International Association for Dental Research, 76th General Session, Symposium "IgA and Periodontal Disease" (1998)
  • IgA and periodontal disease, IADR (1998)
  • Functional characterization of two cloned regions of glucosyltransferase, IADR (1998)
  • The role of IgA and IgG opsonizing antibodies to oral bacteria in promoting the production of cytokines by monocytes, ASM (1998)
  • IgA 1 protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae, ASM (1998)
  • Purification of the recombinant protein SBR-LT-IIa2/B, AADR (1998)
  • Functional characterization of two cloned regions of glucosyltransferase, AADR (1998)
  • Analysis of mucosal and circulating antibody and cytokine responses in gonorrhea: Evidence for immune response evasion by Neisseria gonorrhoeae, Eleventh International Pathogenic Neisseria Conference (1998)
  • Functional aspects of IgA and mucosal immune protection, University of Liverpool (1997)
  • Immunization against mucosal infections: CTA2/B chimeric immunogens, University of Glasgow (1997)
  • Functional Aspects of IgA and Mucosal Immune Protection, University of Liverpool, England (1997)
  • Immunization Against Mucosal Infections: CTA2/B Chimeric Immunogens, University of Glasgow, Scotland (1997)
  • Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery, First International Veterinary Vaccines and Diagnostics Conference (1997)
  • Immune modulation of collagenase release, Gordon Conference on Periodontal Disease (1997)
  • Mucosal immunity and vaccine development, Alcohol and Immunology Research Interest Group (1997)
  • Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery, First International Veterinary Vaccines and Diagnostics Conference (1997)
  • Mucosal Immunity and Vaccine Development, Alcohol and Immunology Research Interest Group (1997)
  • Gordon Research Conference on Periodontal Disease, Gordon Research Conference on Periodontal Disease, New England College (1997)
  • Cholera Toxin B Subunit as an Immunomodulator for Mucosal Vaccine Delivery, First International Veterinary Vaccines and Diagnostics Conference (1997)
  • Novel Approaches to Develop Mucosal Vaccines, 97th General Meeting, American Society for Microbiology, American Society for Microbiology (1997)
  • Construction of glucosyltransferase B-cholera toxin A2/B chimeric proteins, ASM (1997)
  • Generation and function of IgA antibodies for mucosal immune protection, University of Medicine and Dentistry, New Jersey (1997)
  • Generation and Function of IgA Antibodies for Mucosal Immune Protection, University of Medicine and Dentistry New Jersey (1997)
  • Chimeric protein immunogens based on cholera toxin, 97th General Meeting, American Society for Microbiology, colloquium "Host-Parasite Interactions" session 175-E "Novel Approaches to Develop Mucosal Vaccines" (1997)
  • Oral immunization with avirulent S. typhimurium co-expressing S mutans adhesin and mucosal adjuvant, AADR (1997)
  • Streptococcus mutans GS-5 culture supernatant contains glucosyltransferase and a truncated antigen I/II protein, AADR (1997)
  • Purification and characterization of a cell-associated glucosyltransferase from Streptococcus sanguis, AADR (1997)
  • Antibodies in murine vaginal tract depend upon local secretory IgA rather than on serum transudation, AAI (1997)
  • Genetically engineered cellular and molecular mucosal vaccines, 9th International Congress of Mucosal Immunology (1997)
  • Recombinant cholera toxin B subunit as a nasal mucosal adjuvant, 9th International Congress of Mucosal Immunology (1997)
  • Route/antigen delivery system/adjuvant for inducing salivary immune responses, 9th International Congress of Mucosal Immunology (1997)
  • Genetically Engineered Cellular and Molecular Mucosal Vaccines, Ninth International Congress of Mucosal Immunology (1997)
  • Genetically engineered cellular and molecular mucosal vaccines, Ninth International Congress of Mucosal Immunology (1997)
  • IgA antibody as a non-inflammatory regulator of immunity, British Society for Immunology/The Biochemical Society, joint congress, Symposium on Immunoglobulins and Mechanisms of Mucosal Immunity (1996)
  • IgA Antibody as a Non-Inflammatory Regulator of Immunity, Symposium on Immunoglobulins and Mechanisms of Mucosal Immunity, British Society for Immunology/The Biochemical Society, Joint Congress (1996)
  • Mucosal immunoglobulins and their contribution to defense mechanisms, Joing Congress of the Biochemisal Society/British Society for Immunology (1996)
  • IgA antibody as a non-inflammatory regulator of immunity, Symposium on "Immunoglobulins and Mechanisms of Mucosal Immunity", BSI and Biochemical Society Joint Congress (1996)
  • Targeted mucosal immunization: compartmentalization of the common mucosal immune system, 26th annual meeting of the Japanese Society for Immunology (1996)
  • IgA functions, University of Dundee (1996)
  • IgA Functions, University of Dundee (1996)
  • Generation and Function of IgA Antibodies for Mucosal Immune Protection, University of Newcastle (1996)
  • IgA Antibodies for Mucosal Immune Protection, Third International Meeting - Mechanisms in Local Immunity (1996)
  • IgA antibodies for mucosal immune protection, Third International Meeting - Mechanisms in Local Immunity (1996)
  • IgA antibodies for mucosal immune protection, Third International Meeting "Mechanisms in Local Immunity" (1996)
  • IgA Functions, University of Arhus, Department of Medical Microbiology and Immunology (1996)
  • IgA Functions, University of Leiden, The Netherlands, University Hospital, Department of Nephrology (1996)
  • IgA immune complexes suppress the cytokine response of human monocytes to Streptococcus mutans, FASEB Summer Research Conference, "Biology of Fc Receptors" (1996)
  • Targeted mucosal immunization: compartmenetalization of the common mucosal immune system, IABS Task Force on Vaccines (1996)
  • Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant, AAI (1996)
  • Multiple mechanisms of oral tolerance to food antigens in humans, AAI (1996)
  • Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans, 2nd International Meeting on New Approaches to Bacterial Vaccine Development (1996)
  • IgA and Mucosal Immunity: from the Liver Onwards, School of Microbiology and Immunology, University of New South Wales, Symposium to honor the retirement of Professor Graham Jackson (1996)
  • Protection against nasopharyngeal carriage of pneumococci in mice by mucosal immunization with PspA or a capspular type 6B polysaccharide-protein conjugate, ASM (1996)
  • Induction of mucosal immune responses by intranasal immunization using recombinant cholera toxin B subunit (rCTB) as an adjuvant, ASM (1996)
  • Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin, ASM (1996)
  • IgA and Mucosal Immunity: From the Liver Onwards, Symposium to Honor the Retirement of Professor Graham Jackson, School of Microbiology and Immunology, University of New South Wales, Sydney, Australia (1996)
  • Chimeric Protein Subunit Immunogens for Mucosal Immunization Against Caries, Symposium on Molecular Basis of Immunoprophylaxis Against Dental Caries, International Association for Dental Research (1996)
  • Chimeric protein subunit immunogens for mucosal immunization against caries, International Association for Dental Research, Symposium on Molecular Basis of Immunoprophylaxis against Dental Caries (1996)
  • IgA Antibodies for Mucosal Immune Protection, University of Pittsburgh, Dental School (1996)
  • IgA antibodies for mucosal immune protection, University of Pittsburgh (1996)
  • Immunization against mucosal infections: recombinant cholera toxin A2/B chimeric protein immunogens, Southeastern Branch, American Society for Microbiology (1995)
  • Immunization against mucosal infections: recombinant cholera toxin A2/B chimeric protein immunogens, European Science Foundation conference: Immunology of Infections: Mucosal Infections, II (1995)
  • Mucosal immunization with a bacterial protein antigen genetically coupled in cholera toxin A2/B subunits, Mucosal Immunizatiion, Genetic Approaches and Adjuvants (International Business Communications 3rd Annual International Conference (1995)
  • Immunization Against Mucosal Infections: Recombinant Cholera Toxin A2/B Chimeric Protein Immunogens, Immunology of Infections: Mucosal Infections, II, European Science Foundation (1995)
  • Mucosal Immunization with a Bacterial Protein Antigen Genetically Coupled to Cholera Toxin A2/B Subunits, Mucosal Immunization, Genetic Approaches and Adjuvants (International Business Communications 3rd Annual International Conference, International Business Communications (1995)
  • Immunization against mucosal infections: recombinant cholera toxin A2/B chimeric protein immunogens, European Science Foundation conference, Immunology of Infection: Mucosal Infections (1995)
  • Recombinant cholera toxin B subunit-protein chimeric immunogens for mucosal vaccines, 8th International Congress of Mucosal Immunology (1995)
  • Ig isotypes, cytokine profiles, and memory in nasal and gut-associated lymphoid tissues after mucosal immunization, 8th International Congress of Mucosal Immunology (1995)
  • Mucosal immunization of rhesus monkeys with a bacterial protein antigen coupled to cholera toxin B subunit, ASM (1995)
  • Immune memory and dominance of type 2 T cell cytokines in nasal-associated lymphoid tissue (NALT) of mice, AAI (1995)
  • Oral immunization with Streptococcus mutans AgI/II genetically coupled to cholera toxin A2B subunits, AADR (1995)
  • Comparison of IL-8 and GM-CSF on neutrophil phagocytosis of IgA-opsonized particles, AADR (1995)
  • Molecular aspects of IgA in relation to oral immunity, American Association for Dental Research, Symposium on Oral Mucosal Immunity (1995)
  • Molecular Aspects of IgA in Relation to Oral Immunity, Symposium on Oral Mucosal Immunity, American Association for Dental Research (1995)
  • IgA, A Heterogeneous Immunoglobulin with Versatile Functions, Keystone Symposium on "Mucosal Immunity: New Strategies for Protection Against Viral and Bacterial Pathogens", Keystone Symposium (1995)
  • IgA, a heterogeneous immuniglobulin with versatile functions, Keystone Symposium on "Mucosal Immunity: New Strategies for Protection against Viral and Bacterial Pathogens" (1995)
  • IgA, a heterogeneous immunoglobulin with versatile functions, Keystone Symposium on "Mucosal Immunity: New Strategies for Protection against Viral and Bacterial Pathogens (1995)
  • Novel mucosal immunogen genetically constructed from a protein antigen and cholera toxin A2 and B segments, Keystone Symposium on "Mucosal Immunity: New Strategies for Protection against Viral and Bacterial Pathogens" (1995)
  • Roles of inductive sites in region-specific secretory immune responses of diverse mucosal tissues, Keystone Symposium on "Mucosal Immunity: New Strategies for Protection against Viral and Bacterial Pathogens" (1995)
  • Construction of a mucosal immunogen by gene fusion of protein antigen and cholera toxin segments, ASM (1994)
  • Characterization of nasal-associated lymphoid tissue (NALT) in mice, AAI (1994)
  • Dual effect of IgA antibodies on the respiratory burst of neutrophils, AAI (1994)
  • Identeification of functional domains of Streptococcus mutans AgI/II, AADR (1994)
  • Non-inflammatory interactions of human IgA with neutrophils, AADR (1994)
  • Generation of disseminated mucosal immunity by intranasal administration of cholera toxin B subunit-linked antigen, New Advances In Vaccine Technologies and Applications (International Business Communications 2nd Vaccine Strategy Forum (1994)
  • Generation of Disseminated Mucosal Immunity by Intranasal Administration of Cholera Toxin B Subunit-Linked Antigen, New Advances in Vaccine Technologies and Applications, International Business Communications 2nd Vaccine Strategy Forum (1994)
  • Human secretory IgA antibodies inhibit alternative pathway complement activation, AAI (1993)
  • Comparison of T cell responses in associated lymphoid tissues of mice immunized intranasally (i.n.) or intragastrically (i.g.), AAi (1993)
  • Intranasal immunization and mucosal protection by adherence-inhibiting S-IgA antibodies, 24th Annual Meeting, Scandinavian Society for Immunology (1993)
  • Salivary immunity to caries induced by mucosal immunization with S mutans protein Ag I/II, IADR/AADR (1993)
  • Streptococcus mutans cell surface determinants involved in adherence to saliva-coated hydroxyapatite, IADR/AADR (1993)
  • IgA production and transport in the murine liver after mucosal immunization, Seventh International Congress of Mucosal Immunology (1992)
  • IgA Production and Transport in the Murine Liver After Mucosal Immunization, Seventh International Congress of Mucosal Immunology (1992)
  • Distribution of antibody-secreting cells and antibodies in secretions of mice mucosally immunized with S. mutans, FASEB (1992)
  • Streptococcus mutans (Sm) carbohydrate/protein conjugates for immunization studies, AADR (1992)
  • Inhibition of Streptococcus mutans AgI/II binding to saliva-coated hydroxylapatite by S-IgA antibodies, AADR (1992)
  • Achieving and Monitoring Desirable Attributes of a Mucosal Immune Response, NIDR Workshop, Genetically Engineered Vaccines: Prospects for Oral Disease Prevention (1991)
  • Achieving and Monitoring Desirable Attributes of a Mucosal Immune Response, Genetically Engineered Vaccines: Prospects for Oral Disease Prevention, NIDR (1991)
  • Induction and functional activity of bacterial adherence-inhibiting secretory IgA antibodies at mucosal surfaces, ASCB/EMBO Summer Conference "Molecular Cross-Talk between Epithelial Cells and Pathogenic Microorganisms (1991)
  • Differential distribution of specific mucosal antibody responses after peroral immunization with protein-CTB conjugates, FASEB (1991)
  • Phenotypic distribution and cytokine production of T lymphocytes in the mouse liver, FASEB (1991)
  • A mechanism whereby IgA1 proteases may promote invasive infections by mucosal pathogens, Symposium on Microbial Adhesion and Invasion (1990)
  • Oral immunization with protein-CTB conjugates for the induction of mucosal and circulating antibodies, 10th Meeting, European Federation of Immunological Societies (1990)
  • Oral Immunization with Streptococcus mutans Antigen I/II Conjugated to Cholexa Toxin B Subunit, Sixth International Congress of Mucosal Immunology (1990)
  • Oral immunization with Streptococcus mutans antigen I/II Conjugated to Cholera Toxin B Subunit, Sixth International Congress of Mucosal Immunology. Symposium on Dental Caries Vaccines (1990)
  • Human IgA antibodies, or Fab alpha fragments, inhibit IgG antibody-mediate complement fixation by inhibiting C1q binding and subsequent steps, AAI (1990)
  • Antibody-secreting cells in the liver after parenteral or oral immunization in mice, AAI (1990)
  • Lack of immunological cross-reactivity between surface protein antigen I/II of Streptococcus mutans and human heart, FASEB (1990)
  • Anti-inflammatory properties of human IgA antibodies in competition with complement-fixing IgG antibodies, 7th Internatioinal Congress of Immunology (1989)
  • Significance of IgA1 proteases in bacterial infections, Centers for Disease Control, workshop meeting (1989)
  • Significance of IgA1 Proteases in Bacterial Infections, Centers for Disease Control (1989)
  • Anti-inflammatory properties of human IgA antibodies and their Fab fragments, FASEB (1989)
  • Naturally occurring or artificially induced IgA1 and IgA2 antibodies to microbial antigens in human sera and external secretions, 9th European Immunology Meeting (1988)
  • Invited Seminar, University of Turku, Finland, University of Turku, Finland, Dental School, Department of Cariology and Department of Medical Microbiology (1987)
  • Role of the Liver in Mucosal Immunity, University of Iowa, Dows Institute of Dental Research (1987)
  • Analysis of epitopes ini Streptococcus mutans surface protein antigens, 87th Annual Meeting, ASM (1987)
  • Role of the liver in mucosal Immunity, Universitiy of Iowa (1987)
  • IgA and the potential for immunization against oral diseases, University of Iowa (1986)
  • IgA and the Potential for Immunization Against Oral Diseases, University of Iowa, Dows Institute of Dental Research (1986)
  • Western blot analysis of Streptococcus mutans protein antigen I/II and its subcomponents, 72nd Annual Meeting, Southeastern Branch ASM (1986)
  • Specific and non-specific immune responses in mice immunized with Streptococcus mutans, 72nd Annual Meeting, Southeastern Branch, ASM (1986)
  • Induction of the Mucosal Immune Response, Microbial Surfaces: Determinants of Virulence and Host Responsiveness (1986)
  • Induction of the Mucosal Immune Response, Microbial Surfaces: Determinants of Virulence and Host Responsiveness (1986)
  • Investigation of cross-reactivity between heart tissue and Streptococcus mutans, 6th International Congress of Immunology (1986)
  • Immune response to Streptococcus mutans, a model for studies on mucosal immunity, Molecular Genetics, Inc. (1986)
  • Immune Response to Streptococcus mutans, A Model for Studies on Mucosal Immunity, Molecular Genetics, Inc. (1986)
  • Protein Antigens of Streptococcus mutans, International Conference on Cellular, Molecular and Clinical Aspects of Streptococcus mutans (1985)
  • Contribution of Hepatobiliary Transport of IgA to Disposal of Bacterial Antigen Products, International Symposium on Bacteria and the Host (1985)
  • Assay of IgA Subclass Antibodies by Means of Monoclonal Antibodies, Recent Developments in ELISA and Other Solid-Phase Immunoassay Systems (1985)
  • Contribution of Hepatobiliary Transport of IgA to Disposal of Bacterial Antigenic Products, International Symposium on Bacteria and the Host (1985)
  • Assay of IgA Subclass Antibodies by Means of Monoclonal Antibodies, Recent Developments in ELISA and Other Solid-Phase Immunoassay Systems (1985)
  • Enumeration of antibody-secreting cells in mice immunized with Streptococcus mutans, FASEB (1985)
  • Streptococcus mutans Adhesins and Salivary Proteins, 64th General Session of the IADR, IADR/AADR (1985)
  • Streptococcus mutans Adhesins and Salivary Proteins, 64th General Session of the International Association for Dental Research (1985)
  • Binding of Streptococcus mutans and its surface protein antigens to components of saliva, IADR (1985)
  • Streptococcus mutans adhesins and salivary proteins, IADR (1985)
  • Environmental antigens (E Ag) in IgA nephropathy (IgA N), American Society for Clinical Investigation (1985)
  • Human IgA antibodies: significance of subclass 1 and 2 responses to common antigens, Fondation Franco-Allemande (1985)
  • Environmental antigens (E Ag)in IgA nephropathy (IgAN), American Society of Nephrology (1984)
  • Serum IgA antibodies to environmental antigens in patienets with IgA nephropathy, American Association of Immunologists (FASEB) (1984)
  • Interaction of Streptococcus mutans surface proteins with salivary components, International Workshop on Molecular Interactions in Oral Microbial Adherence and Aggregation (1984)
  • Streptococcus mutans Antigens: Characteristics, Functional Aspects, and Use As Anti-Caries Vaccine, Royal Dental College (1984)
  • Streptococcus mutans antigens: characteristics, functional aspects, and use as anti-caries vaccine, Royal Dental College (1984)
  • Salivary antibodies to Streptococcus mutans in caries-free and -active individuals, AADR (1984)
  • Human salivary IgA antibodies prevent Streptococcus mutans colonization, AADR (1984)
  • Protein Antigens of Streptococcus mutans and Their Role in Immunity to Dental Caries, Nihon University Dental School (1983)
  • Protein antigens of Streptococcus mutans and their role in immunity to dental caries, Nihon University (1983)
  • Serum IgA as a monitor of responses to environmental antigens, University of New South Wales (1983)
  • Serum IgA as a Monitor of Responses to Environmental Antigens, University of New South Wales, University of New South Wales, School of Microbiology (1983)
  • The differential control of environmental antigens by serum and secretory IgA, Fifth International Congress of Immunology (1983)
  • Protein antigens of Streptococcus mutans and immunity to dental caries, 9th International Congress on Oral Biology (1983)
  • Reduced IgA mediated hepatobiliary transport of antigens in NZB mice, 67th Annual Meeting, FASEB (1983)
  • Elimination of intestinally absorbed antigen into the bile by IgA, 67th Annual Meeting, FASEB (1983)
  • Ultrastructural localization of protein surface antigens of Streptococcus mutans, AADR (1983)
  • IgA-mediated excretion of bacterial polysaccharide by hepatobiliary transport, 66th Annual Meeting, FASEB (1982)
  • IgA-mediated elimination of antigens by the hepatobiliary route, 66th Annual Meeting, FASEB (1982)
  • Natural immune responses to milk proteins in humans, 66th Annual Meeting, FASEB (1982)
  • Hepatobiliary transport of human immunoglobulins from serum into bile of mice, 66th Annual Meeting, FASEB (1982)
  • IgA and immune complex transport into saliva and other secretions, 60th General Meeting, IADR (1982)
  • Comparison of protein surface antigens from Streptococcus mutans serotypes c and g, 60th General Meeting, IADR (1982)
  • Involvement of the liver in the removal of immune complexes of various immunoglubulin isotypes, 9th International Congress, Reticuloendothelial Society (1982)
  • Antigens of Streptococcus mutans and Dental Caries Immunity in Primates, University of Oklahoma Hjealth Science Center, University of Oklahoma Hjealth Science Center, Department of Biochemistry (1982)
  • Antigens of Streptococcus mutans and dental caries immunity in primates, University of Oklahoma (1982)
  • Hepatobiliary Transport of IgA-Complexed Antigen, British Society for Immunology (1981)
  • Hepatobiliary Transport of IgA-Complexed Antigen, British Society for Immunology (1981)
  • Serum IgA mediates hepatobiliary excretion of antigen, BSI (1981)
  • Invited Seminar, Temple University (1981)
  • The relationship between specific antibodies to streptococcal antigens I, II and III, and protection against dental caries, 29th Meeting, British Division, IADR (1981)
  • Serum IgA mediates hepato-biliary excretion of antigen, 65th Annual Meeting, Federation of American Societieis for Experimental Biology (FASEB) (1981)
  • Mechanisms of Hepatic transport of IgA immune complexes from the circulation into the bile, 65th Annual Meeting, FASEB (1981)
  • Protein Antigens of Streptococcus mutans with Special Reference to Caries Immunity, University of Zurich, Dental Institute (1980)
  • Protein antigens of Streptococcus mutans with special reference to caries immunity, University of Zurich (1980)
  • Invited Seminar, State University of New York at Buffalo, Dental School (1980)
  • Protein surface antigens of Streptococcus mutans, 80th Annual Meeting, American Society for Microbiology (1980)
  • Immunization with a purified protein from Streptococcus mutans and immunoregulation of B cell antibodies by T cell helper activity, 28th Meeting, British Division, IADR (1980)
  • Invited Seminar, University of California at San Francisco, Dental School (1980)
  • Purification and properties of a protein antigen of Streptococcus mutans, 27th Meeting, British Division, IADR (1979)
  • Invited Seminar, University of Groningen, The Netherlands, Dental School/Student Dental Association (1978)
  • Invited Seminar, University of Utrecht, The Netherlands, Dental School (1978)
  • The functions of IgG, IgA and IgM antibodies to Streptococcus mutans in active and passive immunization of monkeys, 26th Meeting, British Division, IADR (1978)
  • Phagocytosis of Streptococcus mutans in relation to protection against dental caries, 26th Meeting, British Division, IADR (1978)
  • Transfer of immunoglubulin from plasma to the mouth in rhesus monkeys, 26th Meeting, British Division, IADR (1978)
  • Transfer of immunoglobulins from plasma to the mouth in rhesus monkeys, BSI (1978)
  • Estimation of the intravascular half-lives of normal rhesus monkey IgG, IgA and IgM, BSI (1978)
  • Separation, purification, and estimation of rhesus monkey serum immunoglobulins; cross-reactivity with human immunoglobulins, British Society for Immunology (1977)
  • Antibodies of defined antigens of Streptococcus mutans in immunity to caries, 25th Meeting, British Division, IADR (1977)
  • Passive transfer of antibodies and cellular immunity in protection against dental caries, 25th Meeting, British Division, IADR (1977)
  • Antibodies and Protective Antibodies to S. mutans, 55th General Session of the IADR (1977)
  • Antibodies and Protective Antibodies to S. mutans, 55th General Session of the International Association for Dental Research (1977)
  • Separation of antigens of Streptococcus mutans and their significance in immunization against dental caries, 24th Meeting, British Division, IADR (1976)
  • Inhibition of glucosyltransferase by sera from rhesus monkeys immunized with Streptococcus mutans, 53rd General Session, International Association for Dental Research (1975)
  • Factors affecting the phagocytosis of Staphylococcus aureus by bovine polymorphonuclear leukocytes in milk, 64th Ordinary Meeting, Society for General Microbilogy (1972)
See All (277 Total) >
Service Activities:
  • School of Medicine & Biomedical Sciences Graduate Affairs, Microbiology and Immunology; Member (2001-2008)

  • American Society for Microbiology, Lecturer; ASM Branch Lectureships (formerly Waksman Foundation for Microbiology Lectures) program.; Guest Lecturer (2008-2010)
  • Academy of Sciences of the Czech Republic - Ad hoc Reviewer; Ad Hoc Reviewer (2008-2008)
  • University of Alabama at Birmingham, School of Dentistry, Visiting Lecturer; Guest Lecturer (2007-2007)
  • Buffalo Collegium of Immunology; Vice President (2007-2009)
  • IADR Distinguished Scientist Awards, Research in Oral Biology Award Committee; Member (2007-2012)
  • Technology Foundation STW, The Netherlands - Ad hoc Reviewer; Ad Hoc Reviewer (2006-2006)
  • Society for Mucosal Immunology: 12th International Congress of Mucosal Immunology; Boston, MA; Member (2005-2005)
  • Associate Editor of Human Vaccines; Associate Editor (2005-2005)
  • International Union of Immunological Sciences WHO/IUS Nomenclature Committee: Subcommittee on MALT Nomenclature; Member (2005)
  • Philip Morris External Research Program Peer Review Panel - Ad hoc Reviewer; Ad Hoc Reviewer (2005-2005)
  • Merieux Foundation International Symposium - Scientific Committee Session II; Merieux Foundation International Symposium on "Plant-Derived Vaccines and Antibodies: Potential and Limitations", Les Pensieres, Veyrier du Lac, Annecy, France, March 2004: member of the Scientific Committee, Chair of Session II "Mucosal Immunization: Induction of Immunity/Tolerance/Allergy by Oral Antigens".; Chair (2004-2004)
  • CSR-ZAII-NBS-M-M4 Special Emphasis Panel; Panel Member (2004-2004)
  • Caries Research - Manuscript Reviewer; Reviewer (2003)
  • Cellular Microbiology - Manuscript Reviewer; Reviewer (2003)
  • Clinical and Vaccine Immunology - Manuscript Reviewer; Reviewer (2003)
  • European Journal of Oral Sciences - Manuscript Reviewer; Reviewer (2003)
  • Human Vaccines - Manuscript Reviewer; Reviewer (2003)
  • Immunological Investigations - Manuscript Reviewer; Reviewer (2003)
  • Infection and Immunity - Manuscript Reviewer; Reviewer (2003)
  • Journal of Dental Research - Manuscript Reviewer; Reviewer (2003)
  • Journal of Immunology - Manuscript Reviewer; Reviewer (2003)
  • Journal of Infectious Diseases - Manuscript Reviewer; Reviewer (2003)
  • Journal of Periodontology - Manuscript Reviewer; Reviewer (2003)
  • Mucosal Immunology - Manuscript Reviewer; Reviewer (2003)
  • Oral Microbiology and Immunology - Manuscript Reviewer; Reviewer (2003)
  • Scandinavian Journal of Immunology - Manuscript Reviewer; Reviewer (2003)
  • Vaccine - Manuscript Reviewer; Reviewer (2003)
  • Editorial Board of Immunological Investigations; Member (2003)
  • Harvard School of Dental Medicine; Visiting Lecturer; Guest Lecturer (2003-2005)
  • Buffalo Collegium of Immunology; Treasurer (2003-2007)
  • IADR Fellowships Committee; Member (2003-2006)
  • CSR ZRG1 VACC 06 Special Emphasis Panel; Member (2003-2003)
  • Society for Mucosal Immunology: 11th International Congress of Mucosal Immunology; Orlando, FL; Member (2002-2002)
  • Philip Morris External Research Program Peer Review Panel - Ad hoc Reviewer; Ad Hoc Reviewer (2002-2002)
  • ASM Press Books Committee; Member (2001-2010)
  • Society for Mucosal Immunology: Nomenclature Committee; Councilor (2000-2002)
  • Natural Sciences and Engineering Research Council, Canada - Ad hoc Reviewer; Ad Hoc Reviewer (2000-2001)
  • American Institute of Biological Sciences/Military Infectious Disease Research Program: Bacterial Diseases Review Panel; Panel Member (2000)
  • AIDS Research and Human Retroviruses - Manuscript Reviewer; Reviewer (2000)
  • Antimicrobial Agents and Chemotherapy - Manuscript Reviewer; Reviewer (2000)
  • Archives of Oral Biology - Manuscript Reviewer; Reviewer (2000)
  • Arthrititis and Rheumatism - Manuscript Reviewer; Reviewer (2000)
  • Biochemical Society Transactions - Manuscript Reviewer; Reviewer (2000)
  • Cellular Immunology - Manuscript Reviewer; Reviewer (2000)
  • Clinical and Diagnostic Laboratory Immunology; Reviewer (2000)
  • Clinical and Experimental Immunology - Manuscript Reviewer; Reviewer (2000)
  • Electrophoresis - Manuscript Reviewer; Reporter (2000)
  • FEBS Letter - Manuscript Reviewer; Reviewer (2000)
  • Gastroenterology - Manuscript Reviewer; Reviewer (2000)
  • Gut - Manuscript Reviewer; Reviewer (2000)
  • Hepatology - Manuscript Reviewer; Reviewer (2000)
  • Immunology - Manuscript Reviewer; Reviewer (2000)
  • Immunology Today/Trends in Immunology - Manuscript Reviewer; Reviewer (2000)
  • International Archives of Allergy and Immunology - Manuscript Reviewer; Reviewer (2000)
  • Journal of Clinical Immunology - Manuscript Reviewer; Reporter (2000)
  • Journal of Clinical Microbiology - Manuscript Reviewer; Reviewer (2000)
  • Journal of Dairy Research - Manuscript Reviewer; Reviewer (2000)
  • Journal of General Microbiology - Manuscript Reviewer; Reviewer (2000)
  • Journal of Immunological Methods - Manuscript Reviewer; Reviewer (2000)
  • Journal of Leukocyte Biology - Manuscript Reviewer; Reviewer (2000)
  • Journal of Reproductive Immunology - Manuscript Reviewer; Reviewer (2000)
  • Microbiological Reviews - Manuscript Reviewer; Reviewer (2000)
  • Nature Biotechnology - Manuscript Reviewer; Reviewer (2000)
  • Nature Medicine - Manuscript Reviewer; Reviewer (2000)
  • Nature Reviews in Immunology - Manuscript Reviewer; Reviewer (2000)
  • Pediatric Research - Manuscript Reviewer; Reviewer (2000)
  • Pharma Sciences - Manuscript Reviewer; Reviewer (2000)
  • Proceedings of the National Academy of Sciences - Manuscript Reviewer; Reviewer (2000)
  • Regional Immunology - Manuscript Reviewer; Reviewer (2000)
  • Science - Manuscript Reviewer; Reviewer (2000)
  • Trends in Microbiology - Manuscript Reviewer; Reporter (2000)
  • Viral Immunology - Manuscript Reviewer; Reviewer (2000)
  • NIDCR Special Emphasis Panel; Member (2000-2000)
  • NIH Vaccine Special Emphasis Panel; Member (1999-1999)
  • Harvard Medical School: Ad hoc Promotion Review Committee; Member (1998-1998)
  • American Society for Microbiology; Divisional Group II Representative, General Meeting Program Committee.; School Representative (1998-2000)
  • American Society for Microbiology; ASM Branch Lectureships (formerly Waksman Foundation for Microbiology Lectures) program.; Committee Member (1997-2007)
  • Society for Mucosal Immunology: 9th International Congress of Mucosal Immunology; Syndey, Australia; Member (1997-1997)
  • International Union of Immunological Sciences WHO/IUS Nomenclature Committee: Subcommittee on IgA Nomenclature; Member (1997-1998)
  • WellBeing/Royal College of Obstetricians and Gynaceologists, U.K. - Ad hoc Reviewer; Ad Hoc Reviewer (1997-1997)
  • Society for Mucosal Immunology: Nomenclature Committee; Chair (1996-1996)
  • American Society for Microbiology; Chair, Division E (Immunology).; Chair (1996-1996)
  • American Society for Microbiology; Chair-Elect, Division E (Immunology).; Chair-Elect (1995-1996)
  • NIDR Special Emphasis Panel; Member (1995-1995)
  • DRG Special Reviewer; Reviewer (1995-1995)
  • NIDR Special Reviewer; Reviewer (1994-1996)
  • Editorial Board of Infection and Immunity; Member (1992-1994)
  • NIAID Program Project Special Review Committee; Member (1992-1992)
  • NCRR Site Visit Review Committee; Member (1992-1992)
  • Editorial Board of Oral Microbiology and Immunology; Member (1991)
  • AADR Hatton Awards Committee; Member (1991-1994)
  • AADR Gies Awards Committee; Member (1991-1994)
  • Veterans Administration - Ad hoc Reviewer; Ad Hoc Reviewer (1990-1990)
  • Thrasher Research Fun - Ad hoc Reviewer; Ad Hoc Reviewer (1990-1990)
See All (95 Total) >

bottom-left cornerbottom-right corner

Contact Information

111 Biomedical Research Building
138 Farber Hall
Buffalo, NY 14214
Phone: (716) 829-2790
Fax: (716) 829-2158
Email: russellm@buffalo.edu


Log in to Update Your Profile